| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 2.16e-08 | 20 | 187 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 9.60e-07 | 36 | 187 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | RGPD4 RGPD2 RANBP2 RNF168 RGPD8 RBBP6 UBR4 RGPD1 CBLC RNF213 TRIM39 CBL RNF220 RGPD3 TRIM37 | 5.47e-06 | 398 | 187 | 15 | GO:0061659 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | RGPD4 RGPD2 RANBP2 RNF168 RGPD8 RBBP6 UBR4 RGPD1 CBLC RNF213 TRIM39 TTC3 CBL RNF220 BRCA1 RGPD3 TRIM37 | 6.89e-06 | 512 | 187 | 17 | GO:0019787 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 7.02e-06 | 50 | 187 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 9.92e-06 | 53 | 187 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | RGPD4 RGPD2 RANBP2 RNF168 RGPD8 RBBP6 UBR4 RGPD1 CBLC RNF213 TRIM39 TTC3 CBL RNF220 BRCA1 RGPD3 TRIM37 | 1.13e-05 | 532 | 187 | 17 | GO:0016755 |
| GeneOntologyMolecularFunction | chromatin binding | KDM3A TCF4 TCF3 ZEB1 RNF168 CHAF1A KAT6A NSD1 ZNF354B BRCA1 GLI3 ATAD2B NKX2-5 TADA2A GRHL3 KAT6B CABIN1 TRIM37 FOXC1 FOXC2 | 2.13e-05 | 739 | 187 | 20 | GO:0003682 |
| GeneOntologyMolecularFunction | acyltransferase activity | RGPD4 RGPD2 RANBP2 RNF168 RGPD8 RBBP6 UBR4 KAT6A RGPD1 CBLC RNF213 TRIM39 TTC3 CBL RNF220 BRCA1 RGPD3 TADA2A KAT6B TRIM37 | 4.16e-05 | 775 | 187 | 20 | GO:0016746 |
| GeneOntologyMolecularFunction | zinc ion binding | TUT4 ZCWPW1 ZEB1 MARCHF10 RBBP6 UBR4 KAT6A NSD1 CBLC TRIM39 ZDBF2 CNBP LIG3 RASGRP1 BRCA1 ADAMTS9 SLFN13 PHF14 TADA2A ZCCHC7 TRIM37 | 9.69e-05 | 891 | 187 | 21 | GO:0008270 |
| GeneOntologyMolecularFunction | E-box binding | 2.66e-04 | 61 | 187 | 5 | GO:0070888 | |
| GeneOntologyMolecularFunction | transition metal ion binding | KDM3A TUT4 ZCWPW1 ZEB1 MARCHF10 RBBP6 UBR4 DCP2 KAT6A NSD1 CBLC COX17 TRIM39 ZDBF2 CNBP LIG3 RASGRP1 BRCA1 ADAMTS9 SLFN13 PHF14 TADA2A ZCCHC7 TRIM37 | 3.19e-04 | 1189 | 187 | 24 | GO:0046914 |
| GeneOntologyMolecularFunction | histone H2A ubiquitin ligase activity | 1.28e-03 | 6 | 187 | 2 | GO:0141053 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 4.07e-11 | 9 | 186 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.01e-10 | 10 | 186 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.04e-10 | 20 | 186 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 8.08e-10 | 13 | 186 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.40e-09 | 14 | 186 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.08e-06 | 38 | 186 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | chromatin organization | KDM3A TCF3 RNF168 SMCHD1 CHAF1A LIN54 KAT6A NSD1 ZDBF2 CHEK1 AXIN1 BPTF BRCA1 SLF2 ATAD2B MKI67 PHF14 TADA2A KAT6B CABIN1 TRIM37 TP53BP1 TDRD12 | 6.30e-06 | 896 | 186 | 23 | GO:0006325 |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 8.94e-06 | 54 | 186 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | KDM3A TCF4 TCF3 RNF168 SMCHD1 CHAF1A LIN54 KAT6A NSD1 ZDBF2 CHEK1 AXIN1 BPTF BRCA1 SLF2 ATAD2B MKI67 PHF14 TADA2A KAT6B CABIN1 TRIM37 TP53BP1 TDRD12 | 1.18e-05 | 999 | 186 | 24 | GO:0071824 |
| GeneOntologyBiologicalProcess | apoptotic process involved in heart morphogenesis | 2.46e-05 | 7 | 186 | 3 | GO:0003278 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | KDM3A TCF3 RNF168 SMCHD1 CHAF1A LIN54 KAT6A NSD1 ZDBF2 CHEK1 AXIN1 BPTF BRCA1 ATAD2B TADA2A KAT6B CABIN1 TRIM37 TDRD12 | 4.31e-05 | 741 | 186 | 19 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 4.37e-05 | 71 | 186 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 7.18e-05 | 195 | 186 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in outflow tract morphogenesis | 8.09e-05 | 2 | 186 | 2 | GO:1902257 | |
| GeneOntologyBiologicalProcess | import into nucleus | 9.06e-05 | 201 | 186 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.62e-04 | 217 | 186 | 9 | GO:0006403 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in outflow tract morphogenesis | 2.41e-04 | 3 | 186 | 2 | GO:0003275 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in outflow tract morphogenesis | 2.41e-04 | 3 | 186 | 2 | GO:1902256 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.30e-11 | 8 | 187 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 9.64e-11 | 10 | 187 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 4.28e-10 | 21 | 187 | 7 | GO:0106068 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.34e-09 | 14 | 187 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | inclusion body | 7.94e-09 | 90 | 187 | 10 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 8.03e-09 | 18 | 187 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.65e-08 | 20 | 187 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear pore | 3.47e-05 | 101 | 187 | 7 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 PMS1 KDM3A RGPD2 TCF4 RANBP2 TCF3 TCF12 RGPD8 LIN54 RGPD1 NSD1 ZNF217 PCF11 BPTF LIG3 YJU2 BRCA1 FRG1 RGPD3 SYNE2 DOCK7 NKX2-5 INTS9 ZCCHC7 PBX1 TRIM37 RGPD5 | 3.86e-05 | 1377 | 187 | 28 | GO:0140513 |
| GeneOntologyCellularComponent | condensed chromosome | CLASP1 CHEK1 RGS12 LIG3 SYCP2 BRCA1 SLF2 MKI67 PINX1 TP53BP1 | 4.63e-04 | 307 | 187 | 10 | GO:0000793 |
| GeneOntologyCellularComponent | DNA repair complex | 1.09e-03 | 23 | 187 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | nuclear body | TCF12 RBBP6 STK17A ZC3H13 KAT6A ZNF217 NOP58 BRCA1 SLF2 GLI3 FRG1 ANGEL2 MKI67 SAFB2 PARN USPL1 TP53BP1 FOXC2 | 1.28e-03 | 903 | 187 | 18 | GO:0016604 |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 1.36e-03 | 91 | 187 | 5 | GO:0000794 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 1.62e-03 | 7 | 187 | 2 | GO:0070776 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.07e-10 | 16 | 143 | 7 | MP:0003701 | |
| MousePheno | abnormal cell nucleus morphology | RGPD4 RGPD2 RANBP2 RGPD8 CHAF1A KAT6A RGPD1 DIDO1 CHEK1 BRCA1 RGPD3 SYNE2 PINX1 TP53BP1 | 5.77e-09 | 184 | 143 | 14 | MP:0003111 |
| MousePheno | abnormal chromosome morphology | RGPD4 RGPD2 RANBP2 RGPD8 KAT6A RGPD1 DIDO1 BRCA1 RGPD3 PINX1 TP53BP1 | 6.49e-08 | 126 | 143 | 11 | MP:0003702 |
| MousePheno | aneuploidy | 1.84e-07 | 61 | 143 | 8 | MP:0004024 | |
| MousePheno | abnormal morula morphology | 2.01e-07 | 26 | 143 | 6 | MP:0012058 | |
| MousePheno | abnormal chromosome number | 2.25e-07 | 86 | 143 | 9 | MP:0004023 | |
| MousePheno | decreased tumor latency | 5.00e-07 | 30 | 143 | 6 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 6.15e-07 | 31 | 143 | 6 | MP:0012129 | |
| MousePheno | enlarged epididymis | 7.55e-07 | 99 | 143 | 9 | MP:0004931 | |
| MousePheno | abnormal tumor latency | 1.10e-06 | 34 | 143 | 6 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 2.55e-06 | 39 | 143 | 6 | MP:0012128 | |
| MousePheno | abnormal mitosis | 6.47e-06 | 128 | 143 | 9 | MP:0004046 | |
| MousePheno | abnormal epididymis size | RGPD4 RGPD2 RANBP2 RGPD8 CLASP1 RGPD1 RGPD3 LRRC17 TDRP TDRD12 | 7.82e-06 | 166 | 143 | 10 | MP:0004926 |
| MousePheno | abnormal intracellular organelle morphology | RGPD4 RGPD2 RANBP2 RGPD8 CHAF1A KAT6A RGPD1 DIDO1 CHEK1 PEX11A CBL GFER BRCA1 RGPD3 SYNE2 PINX1 CORO7 TP53BP1 | 1.16e-05 | 546 | 143 | 18 | MP:0014239 |
| MousePheno | increased respiratory system tumor incidence | 1.37e-05 | 107 | 143 | 8 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 1.37e-05 | 107 | 143 | 8 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 1.37e-05 | 107 | 143 | 8 | MP:0003694 | |
| MousePheno | abnormal sternebra morphology | 1.43e-05 | 52 | 143 | 6 | MP:0004322 | |
| MousePheno | increased lung carcinoma incidence | 1.46e-05 | 78 | 143 | 7 | MP:0008714 | |
| MousePheno | increased hepatobiliary system tumor incidence | 1.79e-05 | 111 | 143 | 8 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 1.79e-05 | 111 | 143 | 8 | MP:0008019 | |
| MousePheno | abnormal blastocyst hatching | 2.04e-05 | 113 | 143 | 8 | MP:0003693 | |
| MousePheno | abnormal cell cycle | RGPD4 RGPD2 RANBP2 ZCWPW1 RNF168 RGPD8 RGPD1 DIDO1 CHEK1 HSF5 LIG3 SYCP2 BRCA1 RGPD3 TP53BP1 PCNT TDRD12 | 2.30e-05 | 520 | 143 | 17 | MP:0003077 |
| MousePheno | eyelids open at birth | 2.70e-05 | 58 | 143 | 6 | MP:0001302 | |
| MousePheno | increased carcinoma incidence | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 BRCA1 RGPD3 PINX1 DNAI7 TRIM37 | 3.46e-05 | 197 | 143 | 10 | MP:0002038 |
| MousePheno | increased organ/body region tumor incidence | RGPD4 RGPD2 RANBP2 TCF3 ZEB1 RGPD8 RGPD1 NLRP6 BRCA1 RGPD3 PINX1 DNAI7 TRIM37 TP53BP1 | 5.34e-05 | 395 | 143 | 14 | MP:0010274 |
| MousePheno | abnormal organ/body region tumor incidence | RGPD4 RGPD2 RANBP2 TCF3 ZEB1 RGPD8 RGPD1 NLRP6 BRCA1 RGPD3 PINX1 DNAI7 TRIM37 TP53BP1 | 6.28e-05 | 401 | 143 | 14 | MP:0013152 |
| MousePheno | increased incidence of induced tumors | 7.13e-05 | 173 | 143 | 9 | MP:0002021 | |
| MousePheno | abnormal susceptibility to weight gain | RGPD4 PCSK1 KDM3A RGPD2 RANBP2 ZEB1 RGPD8 MGAT4A RGPD1 ZNF217 CBL RGPD3 | 7.88e-05 | 309 | 143 | 12 | MP:0011117 |
| MousePheno | increased hepatocellular carcinoma incidence | 7.90e-05 | 70 | 143 | 6 | MP:0003331 | |
| MousePheno | increased sarcoma incidence | 8.31e-05 | 102 | 143 | 7 | MP:0002032 | |
| MousePheno | increased incidence of tumors by chemical induction | 9.93e-05 | 141 | 143 | 8 | MP:0004499 | |
| MousePheno | abnormal incidence of induced tumors | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 NLRP6 BRCA1 RGPD3 MKI67 DNAI7 PLCE1 | 1.00e-04 | 269 | 143 | 11 | MP:0013151 |
| MousePheno | absent epiglottis | 1.04e-04 | 2 | 143 | 2 | MP:0013261 | |
| MousePheno | cornea abrasion | 1.04e-04 | 2 | 143 | 2 | MP:0004105 | |
| MousePheno | abnormal pharyngeal arch artery morphology | 1.13e-04 | 47 | 143 | 5 | MP:0002672 | |
| MousePheno | increased classified tumor incidence | RGPD4 RGPD2 RANBP2 TCF3 ZEB1 RGPD8 RGPD1 BRCA1 RGPD3 PINX1 DNAI7 TRIM37 TP53BP1 | 1.46e-04 | 381 | 143 | 13 | MP:0010273 |
| MousePheno | abnormal testis size | RGPD4 PCSK1 MYO1G KDM3A RGPD2 RANBP2 ZCWPW1 RNF168 RGPD8 CLASP1 BAG5 RGPD1 HSF5 SYCP2 BRCA1 RGPD3 SAFB2 TMF1 TRIM37 FOXC1 PCNT TDRD12 | 1.49e-04 | 915 | 143 | 22 | MP:0004849 |
| MousePheno | abnormal double-negative T cell morphology | 1.50e-04 | 112 | 143 | 7 | MP:0002407 | |
| MousePheno | abnormal classified tumor incidence | RGPD4 RGPD2 RANBP2 TCF3 ZEB1 RGPD8 RGPD1 BRCA1 RGPD3 PINX1 DNAI7 TRIM37 TP53BP1 | 1.57e-04 | 384 | 143 | 13 | MP:0020188 |
| MousePheno | increased malignant tumor incidence | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 BRCA1 RGPD3 PINX1 DNAI7 TRIM37 | 1.62e-04 | 237 | 143 | 10 | MP:0002018 |
| MousePheno | abnormal T cell differentiation | PCSK1 TCF4 TCF3 ZEB1 TCF12 RNF168 KAT6A CD83 CBL RASGRP1 TP53BP1 | 1.77e-04 | 287 | 143 | 11 | MP:0002145 |
| MousePheno | increased energy expenditure | 1.84e-04 | 196 | 143 | 9 | MP:0004889 | |
| MousePheno | embryonic lethality before implantation | RGPD4 PCSK1 RGPD2 RANBP2 RGPD8 CHAF1A RGPD1 CHEK1 GLI3 RGPD3 | 1.92e-04 | 242 | 143 | 10 | MP:0006204 |
| MousePheno | pigmentation phenotype | ZEB1 RNF168 ADAM9 ZC3H13 DCP2 CASR SLC39A10 CBL FRMD4B BRCA1 ADAMTS9 GLI3 GRAMD2B DOCK7 SAFB2 FOXC1 FOXC2 | 2.15e-04 | 624 | 143 | 17 | MP:0001186 |
| MousePheno | abnormal rod electrophysiology | 2.18e-04 | 119 | 143 | 7 | MP:0004021 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 2.38e-04 | 160 | 143 | 8 | MP:0005659 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 2.40e-04 | 203 | 143 | 9 | MP:0011094 | |
| MousePheno | small testis | RGPD4 PCSK1 MYO1G KDM3A RGPD2 RANBP2 ZCWPW1 RNF168 RGPD8 CLASP1 RGPD1 HSF5 SYCP2 BRCA1 RGPD3 TMF1 TRIM37 FOXC1 PCNT TDRD12 | 2.67e-04 | 823 | 143 | 20 | MP:0001147 |
| MousePheno | abnormal respiratory system morphology | RGPD4 RGPD2 RANBP2 FRAS1 ZEB1 RGPD8 BAG5 RGPD1 ANO1 CCDC39 SERPINB10 GLI3 RGPD3 PINX1 NKX2-5 PHF14 MARVELD2 DNAI7 PBX1 DNAH9 FOXC1 PCNT FOXC2 | 2.94e-04 | 1027 | 143 | 23 | MP:0002132 |
| MousePheno | abnormal aortic valve commissure morphology | 3.10e-04 | 3 | 143 | 2 | MP:0031166 | |
| MousePheno | abnormal nasolacrimal duct morphology | 3.10e-04 | 3 | 143 | 2 | MP:0008969 | |
| MousePheno | abnormal primary sex determination | RGPD4 PCSK1 MYO1G KDM3A RGPD2 RANBP2 ZCWPW1 RNF168 RGPD8 CLASP1 RGPD1 HSF5 SYCP2 BRCA1 RGPD3 TMF1 PBX1 TRIM37 FOXC1 PCNT TDRD12 | 3.26e-04 | 901 | 143 | 21 | MP:0002211 |
| MousePheno | fused carpal bones | 3.51e-04 | 14 | 143 | 3 | MP:0008915 | |
| MousePheno | abnormal energy expenditure | RGPD4 PCSK1 KDM3A RGPD2 RANBP2 RGPD8 RGPD1 ZNF217 CBL CCDC7 RGPD3 | 3.73e-04 | 313 | 143 | 11 | MP:0005450 |
| MousePheno | abnormal preimplantation embryo development | 3.73e-04 | 171 | 143 | 8 | MP:0009781 | |
| MousePheno | abnormal epididymis morphology | RGPD4 RGPD2 RANBP2 RGPD8 CLASP1 RGPD1 RGPD3 LRRC17 TDRP TDRD12 | 4.45e-04 | 269 | 143 | 10 | MP:0002631 |
| MousePheno | abnormal energy homeostasis | RGPD4 PCSK1 KDM3A RGPD2 RANBP2 RGPD8 RGPD1 ZNF217 CBL CCDC7 RGPD3 | 4.73e-04 | 322 | 143 | 11 | MP:0005448 |
| MousePheno | abnormal metatarsal bone morphology | 4.80e-04 | 36 | 143 | 4 | MP:0003072 | |
| MousePheno | neoplasm | RGPD4 RGPD2 RANBP2 TCF3 ZEB1 RGPD8 ADAM9 RGPD1 ITGB3 NLRP6 BRCA1 RGPD3 MKI67 PINX1 DNAI7 TRIM37 TP53BP1 PLCE1 | 6.12e-04 | 747 | 143 | 18 | MP:0002006 |
| MousePheno | abnormal sex determination | RGPD4 PCSK1 MYO1G KDM3A RGPD2 RANBP2 ZCWPW1 RNF168 RGPD8 CLASP1 RGPD1 HSF5 SYCP2 BRCA1 RGPD3 TMF1 PBX1 TRIM37 FOXC1 PCNT TDRD12 | 6.13e-04 | 945 | 143 | 21 | MP:0002210 |
| MousePheno | unilateral cleft upper lip | 6.15e-04 | 4 | 143 | 2 | MP:0031447 | |
| MousePheno | iris stroma hypoplasia | 6.15e-04 | 4 | 143 | 2 | MP:0006230 | |
| MousePheno | abnormal embryo development | RGPD4 RGPD2 RANBP2 RGPD8 VEZT RBBP6 ZC3H13 CHAF1A UBR4 RGPD1 NSD1 DIDO1 COX17 CHEK1 CEP164 AXIN1 CNBP BPTF LIG3 BRCA1 ADAMTS9 GLI3 RGPD3 NKX2-5 GRHL3 PBX1 PCNT | 6.39e-04 | 1370 | 143 | 27 | MP:0001672 |
| MousePheno | abnormal fourth pharyngeal arch artery morphology | 6.42e-04 | 17 | 143 | 3 | MP:0006354 | |
| MousePheno | decreased susceptibility to weight gain | 6.52e-04 | 186 | 143 | 8 | MP:0010182 | |
| MousePheno | abnormal preimplantation embryo morphology | RGPD4 RGPD2 RANBP2 RGPD8 SMCHD1 RGPD1 ITGB3 BPTF BRCA1 RGPD3 | 6.61e-04 | 283 | 143 | 10 | MP:0014137 |
| MousePheno | small gonad | RGPD4 PCSK1 MYO1G KDM3A RGPD2 RANBP2 ZCWPW1 RNF168 RGPD8 CLASP1 RGPD1 HSF5 SYCP2 BRCA1 RGPD3 TMF1 TRIM37 FOXC1 PCNT TDRD12 | 6.77e-04 | 885 | 143 | 20 | MP:0001116 |
| MousePheno | increased double-negative T cell number | 6.94e-04 | 69 | 143 | 5 | MP:0005090 | |
| MousePheno | increased single-positive T cell number | 7.21e-04 | 40 | 143 | 4 | MP:0008082 | |
| MousePheno | abnormal tumor incidence | RGPD4 RGPD2 RANBP2 TCF3 ZEB1 RGPD8 RGPD1 NLRP6 BRCA1 RGPD3 MKI67 PINX1 DNAI7 TRIM37 TP53BP1 PLCE1 | 7.79e-04 | 635 | 143 | 16 | MP:0002019 |
| MousePheno | interrupted aortic arch | 7.93e-04 | 41 | 143 | 4 | MP:0004157 | |
| MousePheno | abnormal lung morphology | RGPD4 RGPD2 RANBP2 FRAS1 RGPD8 BAG5 RGPD1 ANO1 CCDC39 SERPINB10 GLI3 RGPD3 PINX1 PHF14 DNAI7 PBX1 PCNT FOXC2 | 8.32e-04 | 767 | 143 | 18 | MP:0001175 |
| MousePheno | interrupted aorta | 9.51e-04 | 43 | 143 | 4 | MP:0010544 | |
| MousePheno | thymus hypoplasia | 9.53e-04 | 152 | 143 | 7 | MP:0001823 | |
| MousePheno | abnormal tumor susceptibility | RGPD4 RGPD2 RANBP2 TCF3 ZEB1 RGPD8 RGPD1 NLRP6 BRCA1 RGPD3 MKI67 PINX1 DNAI7 TRIM37 TP53BP1 PLCE1 | 9.97e-04 | 650 | 143 | 16 | MP:0002166 |
| MousePheno | aortic arch coarctation | 1.02e-03 | 5 | 143 | 2 | MP:0010526 | |
| MousePheno | increased tumor incidence | RGPD4 RGPD2 RANBP2 TCF3 ZEB1 RGPD8 RGPD1 NLRP6 BRCA1 RGPD3 PINX1 DNAI7 TRIM37 TP53BP1 | 1.07e-03 | 530 | 143 | 14 | MP:0002020 |
| MousePheno | abnormal iridocorneal angle | 1.22e-03 | 21 | 143 | 3 | MP:0004221 | |
| MousePheno | abnormal metanephros morphology | 1.22e-03 | 21 | 143 | 3 | MP:0011364 | |
| MousePheno | decreased pro-B cell number | 1.23e-03 | 46 | 143 | 4 | MP:0008208 | |
| MousePheno | abnormal germ layer morphology | 1.33e-03 | 161 | 143 | 7 | MP:0014138 | |
| Domain | Ran_BP1 | 6.34e-12 | 12 | 185 | 7 | PF00638 | |
| Domain | RANBD1 | 6.34e-12 | 12 | 185 | 7 | PS50196 | |
| Domain | RanBD | 1.36e-11 | 13 | 185 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 1.36e-11 | 13 | 185 | 7 | IPR000156 | |
| Domain | Grip | 3.86e-10 | 11 | 185 | 6 | SM00755 | |
| Domain | GRIP | 3.86e-10 | 11 | 185 | 6 | PF01465 | |
| Domain | GRIP_dom | 7.66e-10 | 12 | 185 | 6 | IPR000237 | |
| Domain | GRIP | 7.66e-10 | 12 | 185 | 6 | PS50913 | |
| Domain | Rab_bind | 1.87e-09 | 7 | 185 | 5 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.87e-09 | 7 | 185 | 5 | IPR032023 | |
| Domain | - | 2.19e-08 | 10 | 185 | 5 | 1.10.220.60 | |
| Domain | - | RNF168 MARCHF10 RBBP6 KAT6A NSD1 CBLC RNF213 DIDO1 TRIM39 TTC3 CBL BPTF RNF220 BRCA1 PHF14 KAT6B TRIM37 | 2.50e-06 | 449 | 185 | 17 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | RNF168 MARCHF10 RBBP6 KAT6A NSD1 CBLC RNF213 DIDO1 TRIM39 TTC3 CBL BPTF RNF220 BRCA1 PHF14 KAT6B TRIM37 | 3.36e-06 | 459 | 185 | 17 | IPR013083 |
| Domain | TPR-contain_dom | 1.89e-05 | 150 | 185 | 9 | IPR013026 | |
| Domain | Znf_RING | RNF168 MARCHF10 RBBP6 KAT6A NSD1 CBLC RNF213 TRIM39 TTC3 CBL RNF220 BRCA1 TRIM37 | 2.32e-05 | 326 | 185 | 13 | IPR001841 |
| Domain | TPR_REGION | 4.01e-05 | 165 | 185 | 9 | PS50293 | |
| Domain | TPR | 4.01e-05 | 165 | 185 | 9 | PS50005 | |
| Domain | TPR | 4.38e-05 | 129 | 185 | 8 | SM00028 | |
| Domain | TPR_repeat | 5.44e-05 | 133 | 185 | 8 | IPR019734 | |
| Domain | RING | RNF168 RBBP6 KAT6A NSD1 CBLC RNF213 TRIM39 TTC3 CBL RNF220 BRCA1 TRIM37 | 5.47e-05 | 305 | 185 | 12 | SM00184 |
| Domain | zf-CCHC | 7.12e-05 | 23 | 185 | 4 | PF00098 | |
| Domain | A1A_glycop | 9.76e-05 | 2 | 185 | 2 | IPR001500 | |
| Domain | PHD | 9.95e-05 | 75 | 185 | 6 | PF00628 | |
| Domain | - | 1.17e-04 | 26 | 185 | 4 | 4.10.60.10 | |
| Domain | Znf_PHD-finger | 1.33e-04 | 79 | 185 | 6 | IPR019787 | |
| Domain | PHD | 2.56e-04 | 89 | 185 | 6 | SM00249 | |
| Domain | Znf_PHD | 2.89e-04 | 91 | 185 | 6 | IPR001965 | |
| Domain | Adaptor_Cbl_EF_hand-like | 2.91e-04 | 3 | 185 | 2 | IPR014741 | |
| Domain | Adaptor_Cbl_SH2-like | 2.91e-04 | 3 | 185 | 2 | IPR014742 | |
| Domain | Adaptor_Cbl | 2.91e-04 | 3 | 185 | 2 | IPR024162 | |
| Domain | Cbl_PTB | 2.91e-04 | 3 | 185 | 2 | IPR024159 | |
| Domain | Cbl_N2 | 2.91e-04 | 3 | 185 | 2 | PF02761 | |
| Domain | Cbl_N3 | 2.91e-04 | 3 | 185 | 2 | PF02762 | |
| Domain | Cbl_N | 2.91e-04 | 3 | 185 | 2 | PF02262 | |
| Domain | Adaptor_Cbl_N_hlx | 2.91e-04 | 3 | 185 | 2 | IPR003153 | |
| Domain | CBL_PTB | 2.91e-04 | 3 | 185 | 2 | PS51506 | |
| Domain | - | 2.91e-04 | 3 | 185 | 2 | 1.20.930.20 | |
| Domain | Znf_C3HC4_RING-type | 3.22e-04 | 172 | 185 | 8 | IPR018957 | |
| Domain | PH_dom-like | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 DOCK10 FRMD4B RGS12 CADPS RGPD3 FRMPD3 PLCE1 RGPD5 | 3.37e-04 | 426 | 185 | 13 | IPR011993 |
| Domain | ZF_PHD_2 | 3.65e-04 | 95 | 185 | 6 | PS50016 | |
| Domain | ZF_CCHC | 3.84e-04 | 35 | 185 | 4 | PS50158 | |
| Domain | ZF_PHD_1 | 3.86e-04 | 96 | 185 | 6 | PS01359 | |
| Domain | TPR-like_helical_dom | 5.39e-04 | 233 | 185 | 9 | IPR011990 | |
| Domain | Znf_FYVE_PHD | 6.63e-04 | 147 | 185 | 7 | IPR011011 | |
| Domain | ZF_RING_2 | RNF168 RBBP6 CBLC RNF213 TRIM39 TTC3 CBL RNF220 BRCA1 TRIM37 | 8.00e-04 | 298 | 185 | 10 | PS50089 |
| Domain | HAT_MYST-type | 9.57e-04 | 5 | 185 | 2 | IPR002717 | |
| Domain | MOZ_SAS | 9.57e-04 | 5 | 185 | 2 | PF01853 | |
| Domain | Nlgn | 9.57e-04 | 5 | 185 | 2 | IPR000460 | |
| Domain | MYST_HAT | 9.57e-04 | 5 | 185 | 2 | PS51726 | |
| Domain | - | 1.09e-03 | 207 | 185 | 8 | 1.25.40.10 | |
| Domain | BRCT | 1.28e-03 | 22 | 185 | 3 | SM00292 | |
| Domain | SPOC_C | 1.43e-03 | 6 | 185 | 2 | IPR012921 | |
| Domain | DUF3398 | 1.43e-03 | 6 | 185 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 1.43e-03 | 6 | 185 | 2 | IPR021816 | |
| Domain | SPOC | 1.43e-03 | 6 | 185 | 2 | PF07744 | |
| Domain | - | 1.46e-03 | 23 | 185 | 3 | 3.40.50.10190 | |
| Domain | zf-C3HC4 | 1.75e-03 | 223 | 185 | 8 | PF00097 | |
| Domain | - | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 DOCK10 FRMD4B RGS12 CADPS RGPD3 PLCE1 | 1.84e-03 | 391 | 185 | 11 | 2.30.29.30 |
| Domain | TPR_1 | 2.01e-03 | 90 | 185 | 5 | IPR001440 | |
| Domain | TPR_1 | 2.01e-03 | 90 | 185 | 5 | PF00515 | |
| Domain | BRCT | 2.10e-03 | 26 | 185 | 3 | PS50172 | |
| Domain | ZnF_C2HC | 2.14e-03 | 55 | 185 | 4 | SM00343 | |
| Domain | Znf_CCHC | 2.14e-03 | 55 | 185 | 4 | IPR001878 | |
| Domain | ZF_RING_1 | 2.53e-03 | 291 | 185 | 9 | PS00518 | |
| Domain | BRCT_dom | 2.61e-03 | 28 | 185 | 3 | IPR001357 | |
| Domain | RPR | 2.63e-03 | 8 | 185 | 2 | SM00582 | |
| Domain | CID_dom | 2.63e-03 | 8 | 185 | 2 | IPR006569 | |
| Domain | CID | 2.63e-03 | 8 | 185 | 2 | PS51391 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 8.07e-09 | 18 | 127 | 6 | MM1549 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.86e-07 | 73 | 127 | 8 | MM14948 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 8.37e-07 | 58 | 127 | 7 | MM15149 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 8.54e-07 | 84 | 127 | 8 | MM14929 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.42e-06 | 40 | 127 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.65e-06 | 41 | 127 | 6 | MM15200 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.72e-06 | 92 | 127 | 8 | MM14951 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.91e-06 | 42 | 127 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.20e-06 | 43 | 127 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION | RGPD4 RGPD2 RANBP2 RNF168 RGPD8 RGPD1 NOP58 BRCA1 RGPD3 TP53BP1 | 2.94e-06 | 169 | 127 | 10 | MM14919 |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 3.77e-06 | 47 | 127 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 4.84e-06 | 49 | 127 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 5.45e-06 | 50 | 127 | 6 | MM14610 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | RGPD4 RGPD2 RANBP2 RNF168 RGPD8 CLASP1 RGPD1 PSMC2 CHEK1 BRCA1 RGPD3 TP53BP1 | 6.03e-06 | 271 | 127 | 12 | MM15388 |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 6.14e-06 | 51 | 127 | 6 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 9.59e-06 | 55 | 127 | 6 | MM14917 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.31e-05 | 58 | 127 | 6 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.54e-05 | 65 | 127 | 6 | MM15147 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 3.26e-05 | 100 | 127 | 7 | MM14561 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 8.91e-05 | 117 | 127 | 7 | MM15387 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 9.50e-05 | 82 | 127 | 6 | MM15394 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.24e-04 | 86 | 127 | 6 | MM15413 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.64e-04 | 129 | 127 | 7 | MM14894 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.66e-04 | 234 | 127 | 9 | MM14898 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.84e-04 | 141 | 127 | 7 | MM15266 | |
| Pathway | REACTOME_CELL_CYCLE | RGPD4 RGPD2 RANBP2 RNF168 RGPD8 CLASP1 LIN54 RGPD1 PSMC2 CHEK1 ANKLE2 CEP164 BRCA1 RGPD3 TP53BP1 | 3.41e-04 | 603 | 127 | 15 | MM14635 |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 3.57e-04 | 193 | 127 | 8 | MM14890 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 4.84e-04 | 202 | 127 | 8 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 5.73e-04 | 114 | 127 | 6 | MM15361 | |
| Pathway | WP_HEART_DEVELOPMENT | 7.65e-04 | 46 | 127 | 4 | MM15884 | |
| Pathway | WP_HEART_DEVELOPMENT | 8.30e-04 | 47 | 127 | 4 | M39610 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 9.01e-04 | 277 | 127 | 9 | MM15414 | |
| Pathway | WP_GDNFRET_SIGNALING_AXIS | 9.70e-04 | 22 | 127 | 3 | MM15887 | |
| Pathway | WP_GDNFRET_SIGNALING_AXIS | 1.11e-03 | 23 | 127 | 3 | M39814 | |
| Pathway | REACTOME_MYOGENESIS | 1.26e-03 | 24 | 127 | 3 | MM15174 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PMS1 RANBP2 VEZF1 RBBP6 ZC3H13 SMCHD1 CHAF1A LIN54 U2SURP RBM26 NSD1 SRP14 DIDO1 ZDBF2 PCF11 CNBP LENG8 BPTF LIG3 NOP58 BRCA1 SLF2 ATAD2B MKI67 SAFB2 PINX1 NKX2-5 PHF14 PARN ZCCHC7 SPEN TP53BP1 FOXC1 | 1.91e-17 | 954 | 188 | 33 | 36373674 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PMS1 KDM3A RNF168 VEZF1 SMCHD1 CHAF1A LIN54 KAT6A NSD1 DIDO1 BPTF LIG3 RNF220 NOP58 TRMT6 BRCA1 FRG1 ATAD2B ZBTB21 MKI67 PINX1 PHF14 CABIN1 SPEN FOXC1 | 4.34e-15 | 608 | 188 | 25 | 36089195 |
| Pubmed | RGPD4 RGPD2 MYH3 FLNC RANBP2 RGPD8 VEZF1 HSPA4L SMCHD1 CHAF1A LIN54 U2SURP UBR4 SANBR RGPD1 SRP14 FAM47B PEX11A TTC3 ANKLE2 ERLEC1 PCF11 BPTF BRCA1 RGPD3 SYNE2 ZBTB21 SAFB2 UGGT2 PHF14 GPR171 USPL1 SPEN ERICH6 PCNT RGPD5 | 1.39e-14 | 1442 | 188 | 36 | 35575683 | |
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 9037092 | ||
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 21205196 | ||
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 24403063 | ||
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 23536549 | ||
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 12191015 | ||
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 22821000 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.60e-13 | 7 | 188 | 6 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.60e-13 | 7 | 188 | 6 | 11353387 | |
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 30944974 | ||
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.60e-13 | 7 | 188 | 6 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.60e-13 | 7 | 188 | 6 | 17372272 | |
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 38657106 | ||
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 18949001 | ||
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 25187515 | ||
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 8603673 | ||
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 26632511 | ||
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 23818861 | ||
| Pubmed | 1.60e-13 | 7 | 188 | 6 | 20682751 | ||
| Pubmed | TCF4 TCF3 ZEB1 TCF12 VEZF1 HSPA4L RBBP6 SMCHD1 LIN54 UBR4 BAG5 RGPD1 PSMC2 DIDO1 ZNF217 LARP4 PCF11 CNBP LENG8 BPTF FHAD1 LIG3 BRCA1 GLI3 SYNE2 ZBTB21 MKI67 NKX2-5 TADA2A PBX1 CABIN1 SPEN TP53BP1 FOXC1 | 3.26e-13 | 1429 | 188 | 34 | 35140242 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | RBBP6 SMCHD1 UBR4 RBM26 SRP14 RNF213 DIDO1 LENG8 BPTF LIG3 FRG1 MKI67 SAFB2 INTS9 PARN KAT6B SPEN TP53BP1 | 5.76e-13 | 341 | 188 | 18 | 32971831 |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 6.39e-13 | 8 | 188 | 6 | 21670213 | |
| Pubmed | 6.39e-13 | 8 | 188 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 6.39e-13 | 8 | 188 | 6 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 6.39e-13 | 8 | 188 | 6 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 6.39e-13 | 8 | 188 | 6 | 28745977 | |
| Pubmed | 1.91e-12 | 9 | 188 | 6 | 28100513 | ||
| Pubmed | 1.91e-12 | 9 | 188 | 6 | 17887960 | ||
| Pubmed | 1.91e-12 | 9 | 188 | 6 | 9733766 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.91e-12 | 9 | 188 | 6 | 18394993 | |
| Pubmed | 1.91e-12 | 9 | 188 | 6 | 11553612 | ||
| Pubmed | 1.91e-12 | 9 | 188 | 6 | 10601307 | ||
| Pubmed | 1.91e-12 | 9 | 188 | 6 | 28877029 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 4.75e-12 | 10 | 188 | 6 | 16332688 | |
| Pubmed | 4.75e-12 | 10 | 188 | 6 | 27160050 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 4.75e-12 | 10 | 188 | 6 | 8857542 | |
| Pubmed | 4.75e-12 | 10 | 188 | 6 | 21859863 | ||
| Pubmed | 1.04e-11 | 11 | 188 | 6 | 17069463 | ||
| Pubmed | 1.04e-11 | 11 | 188 | 6 | 34110283 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.04e-11 | 11 | 188 | 6 | 35771867 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RANBP2 TCF3 RNF168 VEZF1 RBBP6 ZC3H13 SMCHD1 CHAF1A LIN54 U2SURP NSD1 SRP14 DIDO1 BPTF LIG3 NOP58 BRCA1 SLF2 FRG1 RGPD3 MKI67 SAFB2 INTS9 PHF14 TADA2A DNAJC1 ZCCHC7 CABIN1 SPEN FOXC1 | 1.82e-11 | 1294 | 188 | 30 | 30804502 |
| Pubmed | 1.92e-11 | 22 | 188 | 7 | 27717094 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 3.83e-11 | 13 | 188 | 6 | 31427429 | |
| Pubmed | RGPD4 RGPD2 RANBP2 MIA3 ZEB1 RGPD8 CLASP1 ADAM9 UBR4 RGPD1 NSD1 DIDO1 ARMCX4 TTC3 NLGN3 RGPD3 SYNE2 ZBTB21 DOCK7 SAFB2 PARN FRMPD3 CABIN1 TP53BP1 PCNT | 1.01e-10 | 963 | 188 | 25 | 28671696 | |
| Pubmed | 1.11e-10 | 15 | 188 | 6 | 14697343 | ||
| Pubmed | RGPD4 RGPD2 RANBP2 ZEB1 RGPD8 LIN54 UBR4 RGPD1 ZDBF2 ZNF217 CHEK1 RGPD3 ZBTB21 DOCK7 TMF1 TADA2A PCNT | 1.55e-10 | 418 | 188 | 17 | 34709266 | |
| Pubmed | KDM3A RANBP2 TCF3 TCF12 VEZF1 CLASP1 SMCHD1 LIN54 U2SURP RBM26 SRP14 DIDO1 ZNF217 CHEK1 CCDC7 PCF11 LENG8 BPTF NOP58 BRCA1 FRG1 ZBTB21 MKI67 SAFB2 SPEN TP53BP1 | 3.27e-10 | 1103 | 188 | 26 | 34189442 | |
| Pubmed | FLNC RANBP2 ZC3H13 SMCHD1 U2SURP UBR4 NSD1 PSMC2 DIDO1 LARP4 BPTF NOP58 ATAD2B SYNE2 MKI67 DOCK7 PARN SPEN TP53BP1 PCNT | 5.18e-10 | 653 | 188 | 20 | 22586326 | |
| Pubmed | 1.04e-09 | 86 | 188 | 9 | 37253089 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 KDM3A RANBP2 ZEB1 CLASP1 RBBP6 ZC3H13 CHAF1A TATDN2 CBLC DIDO1 ZNF217 PCF11 BPTF ZBTB21 MKI67 SAFB2 PHF14 KAT6B SPEN TP53BP1 | 1.63e-09 | 774 | 188 | 21 | 15302935 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNC RANBP2 DSC1 SMCHD1 CHAF1A U2SURP RBM26 PSMC2 SRP14 DIDO1 ZNF217 SLC39A10 CNBP LENG8 BPTF NOP58 FRG1 MKI67 SAFB2 PINX1 PHF14 PARN TP53BP1 | 4.83e-09 | 989 | 188 | 23 | 36424410 |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | RGPD4 RGPD2 RANBP2 RGPD8 CHAF1A UBR4 RGPD1 BRCA1 RGPD3 TP53BP1 | 1.23e-08 | 153 | 188 | 10 | 26365490 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ZNF280A PMS1 KDM3A FLNC RANBP2 TCF12 SMCHD1 LIN54 LARP4 LIG3 RNF220 SLF2 RGPD3 ZBTB21 CORO7 | 2.31e-08 | 444 | 188 | 15 | 34795231 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TCF4 FLNC RANBP2 ZCWPW1 TCF12 CHAF1A LIN54 UBR4 RBM26 BPTF LIG3 ZBTB21 TMF1 NKX2-5 PBX1 CABIN1 SPEN TP53BP1 FOXC1 FOXC2 | 4.93e-08 | 857 | 188 | 20 | 25609649 |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 5.51e-08 | 38 | 188 | 6 | 12791264 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 5.66e-08 | 135 | 188 | 9 | 31077711 | |
| Pubmed | E2-2 regulates the expansion of pro-B cells and follicular versus marginal zone decisions. | 1.55e-07 | 3 | 188 | 3 | 17082585 | |
| Pubmed | 1.55e-07 | 3 | 188 | 3 | 34555355 | ||
| Pubmed | 1.55e-07 | 3 | 188 | 3 | 1321336 | ||
| Pubmed | 1.55e-07 | 3 | 188 | 3 | 18384878 | ||
| Pubmed | The helix-loop-helix gene E2A is required for B cell formation. | 1.55e-07 | 3 | 188 | 3 | 8001124 | |
| Pubmed | 1.55e-07 | 3 | 188 | 3 | 30593567 | ||
| Pubmed | 1.55e-07 | 3 | 188 | 3 | 8649400 | ||
| Pubmed | KDM3A RBBP6 SMCHD1 RBM26 NSD1 PSMC2 DIDO1 CBL CNBP BPTF NOP58 DOCK7 SPEN TP53BP1 RGPD5 | 3.56e-07 | 549 | 188 | 15 | 38280479 | |
| Pubmed | MIA3 TUT4 RGPD8 CLASP1 VEZT CHAF1A RBM26 RNF213 ZDBF2 LARP4 FRMD4B ERLEC1 TMF1 UGGT2 PRR14L DNAJC1 CORO7 | 5.72e-07 | 733 | 188 | 17 | 34672954 | |
| Pubmed | 6.19e-07 | 4 | 188 | 3 | 11802795 | ||
| Pubmed | Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma. | 6.19e-07 | 4 | 188 | 3 | 21771727 | |
| Pubmed | 6.19e-07 | 4 | 188 | 3 | 21552324 | ||
| Pubmed | The Foxc2 transcription factor regulates angiogenesis via induction of integrin beta3 expression. | 6.19e-07 | 4 | 188 | 3 | 18579532 | |
| Pubmed | 6.19e-07 | 4 | 188 | 3 | 9480752 | ||
| Pubmed | 6.19e-07 | 4 | 188 | 3 | 24561620 | ||
| Pubmed | 6.19e-07 | 4 | 188 | 3 | 25466284 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | FLNC RANBP2 MIA3 ZEB1 RNF168 DSC1 VEZF1 CLASP1 RBBP6 ADAM9 SLC39A10 CBL AXIN1 NOP58 FAM111A GLI3 MKI67 DOCK7 SAFB2 DNAJC1 ZCCHC7 TP53BP1 | 6.74e-07 | 1203 | 188 | 22 | 29180619 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 7.88e-07 | 184 | 188 | 9 | 32908313 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | RGPD4 KDM3A RGPD2 RANBP2 CLASP1 HSPA4L RGPD1 DOCK10 ERLEC1 CAPN13 TRMT44 RGPD3 RGPD5 | 9.76e-07 | 442 | 188 | 13 | 15815621 |
| Pubmed | 1.18e-06 | 99 | 188 | 7 | 27746211 | ||
| Pubmed | FILIP1 RANBP2 RNF168 RBBP6 NSD1 RNF213 BPTF BRCA1 MKI67 TP53BP1 | 1.20e-06 | 250 | 188 | 10 | 33536335 | |
| Pubmed | 1.24e-06 | 251 | 188 | 10 | 31076518 | ||
| Pubmed | ZEB1 TCF12 RNF168 SMCHD1 NSD1 LIG3 FAM111A BRCA1 SLF2 INTS9 PARN CABIN1 TP53BP1 | 1.28e-06 | 453 | 188 | 13 | 29656893 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.40e-06 | 146 | 188 | 8 | 23892456 | |
| Pubmed | TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes. | 1.54e-06 | 5 | 188 | 3 | 22884692 | |
| Pubmed | Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response. | 1.54e-06 | 5 | 188 | 3 | 31501315 | |
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 8999959 | ||
| Pubmed | TCF4 TCF3 TCF12 VEZF1 DIDO1 ZNF217 CBL CNBP HOXB8 BRCA1 GLI3 MKI67 PHF14 PBX1 KAT6B FOXC2 | 1.77e-06 | 709 | 188 | 16 | 22988430 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 2.26e-06 | 109 | 188 | 7 | 33554859 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | RGPD2 RANBP2 U2SURP RBM26 RGPD1 DIDO1 BPTF MKI67 PHF14 TP53BP1 | 2.47e-06 | 271 | 188 | 10 | 32433965 |
| Pubmed | FRAS1 CLASP1 ADAM9 DOCK10 SPOCK2 NLGN1 SLC39A10 CADPS DOCK7 SPEN PCNT PLCE1 | 2.51e-06 | 407 | 188 | 12 | 12693553 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | MYH3 FRAS1 DOCK10 DIDO1 LENG8 NOP58 FAM111A FRG1 MKI67 DOCK7 ZCCHC7 SPEN | 2.71e-06 | 410 | 188 | 12 | 26949251 |
| Pubmed | RANBP2 RNF168 RBBP6 SMCHD1 CHAF1A UBR4 RBM26 SRP14 RNF213 DIDO1 BPTF LIG3 NOP58 YJU2 ZBTB21 MKI67 SAFB2 PHF14 PARN | 2.88e-06 | 1014 | 188 | 19 | 32416067 | |
| Pubmed | PMS1 FRAS1 MIA3 TCF12 ADAM9 DOCK10 DIDO1 ITGB3 LIG3 MTIF2 DOCK7 UGGT2 PARN AP4B1 PLCE1 | 2.88e-06 | 650 | 188 | 15 | 38777146 | |
| Pubmed | Asb2α-Filamin A Axis Is Essential for Actin Cytoskeleton Remodeling During Heart Development. | 3.01e-06 | 19 | 188 | 4 | 29374072 | |
| Pubmed | TUT4 TCF12 VEZT RBBP6 CHAF1A KAT6A SRP14 RNF213 CHEK1 BPTF BRCA1 CADPS MTIF2 TRABD GLI3 ZBTB21 TADA2A KAT6B UNC80 FOXC1 | 3.04e-06 | 1116 | 188 | 20 | 31753913 | |
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 31009828 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 17878293 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 9584154 | ||
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 10611232 | ||
| Pubmed | Differential cooperation between dHAND and three different E-proteins. | 3.07e-06 | 6 | 188 | 3 | 15351717 | |
| Interaction | NUP43 interactions | KDM3A RANBP2 DSC1 RGPD8 RBBP6 ZC3H13 LIN54 RBM26 NSD1 ZDBF2 CCDC168 GFER BPTF LIG3 RNF220 NOP58 BRCA1 SLF2 FRG1 ATAD2B SYNE2 MKI67 PARN ZCCHC7 SPEN DNAH9 RGPD5 | 2.86e-11 | 625 | 187 | 27 | int:NUP43 |
| Interaction | TERF2IP interactions | PMS1 KDM3A ZEB1 RBBP6 SMCHD1 CHAF1A LIN54 U2SURP NSD1 SRP14 DIDO1 PCF11 BPTF LIG3 TRMT6 YJU2 BRCA1 ZBTB21 MKI67 PINX1 INTS9 PARN SPEN PEA15 FOXC1 | 6.14e-11 | 552 | 187 | 25 | int:TERF2IP |
| Interaction | SMC5 interactions | PMS1 RANBP2 VEZF1 RBBP6 ZC3H13 SMCHD1 CHAF1A LIN54 U2SURP RBM26 NSD1 SRP14 DIDO1 ZDBF2 PCF11 CNBP LENG8 BPTF LIG3 NOP58 BRCA1 SLF2 ATAD2B MKI67 SAFB2 PINX1 NKX2-5 PHF14 PARN ZCCHC7 SPEN TP53BP1 FOXC1 | 1.86e-10 | 1000 | 187 | 33 | int:SMC5 |
| Interaction | RGPD4 interactions | 8.02e-10 | 22 | 187 | 7 | int:RGPD4 | |
| Interaction | H3C3 interactions | PMS1 KDM3A RNF168 VEZF1 SMCHD1 CHAF1A LIN54 NSD1 DIDO1 BPTF LIG3 RNF220 NOP58 TRMT6 BRCA1 FRG1 ATAD2B MKI67 PINX1 PHF14 SPEN FOXC1 | 1.34e-09 | 495 | 187 | 22 | int:H3C3 |
| Interaction | RGPD2 interactions | 4.02e-09 | 27 | 187 | 7 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 2.43e-07 | 47 | 187 | 7 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 3.27e-07 | 49 | 187 | 7 | int:RGPD1 | |
| Interaction | H3-3A interactions | PMS1 KDM3A VEZF1 SMCHD1 CHAF1A LIN54 KAT6A NSD1 DIDO1 BPTF LIG3 RNF220 TRMT6 BRCA1 FRG1 ATAD2B ZBTB21 MKI67 PINX1 PHF14 CABIN1 SPEN FOXC1 | 4.99e-07 | 749 | 187 | 23 | int:H3-3A |
| Interaction | SNRNP40 interactions | PMS1 KDM3A TCF12 VEZF1 RBBP6 ZC3H13 KAT6A ZDBF2 ZNF217 LENG8 NOP58 YJU2 BRCA1 ATAD2B ZBTB21 MKI67 PINX1 INTS9 ZCCHC7 SPEN FOXC1 | 5.21e-07 | 637 | 187 | 21 | int:SNRNP40 |
| Interaction | CBX3 interactions | KDM3A ZEB1 VEZF1 RBBP6 ZC3H13 SMCHD1 CHAF1A LIN54 NSD1 TRIM39 ZNF217 PEX11A LIG3 YJU2 BRCA1 ZBTB21 MKI67 PINX1 SPEN TP53BP1 | 2.58e-06 | 646 | 187 | 20 | int:CBX3 |
| Interaction | RGPD8 interactions | 5.64e-06 | 74 | 187 | 7 | int:RGPD8 | |
| Interaction | KDM1A interactions | ZNF280A TCF4 RANBP2 TCF3 ZEB1 RNF168 CHAF1A LIN54 UBR4 TRIM39 ZDBF2 ZNF217 CHEK1 GFER LENG8 BRCA1 ZBTB21 DOCK7 TMF1 ZNF480 TADA2A TP53BP1 FOXC1 PCNT | 7.03e-06 | 941 | 187 | 24 | int:KDM1A |
| Interaction | MEN1 interactions | TCF3 RBBP6 ZC3H13 SMCHD1 U2SURP UBR4 RBM26 SRP14 RNF213 DIDO1 CHEK1 PCF11 LENG8 BPTF LIG3 NOP58 FRG1 MKI67 SAFB2 INTS9 PARN KAT6B SPEN TP53BP1 FOXC1 | 1.03e-05 | 1029 | 187 | 25 | int:MEN1 |
| Interaction | CEBPA interactions | KDM3A RANBP2 TCF3 TCF12 VEZF1 CLASP1 SMCHD1 LIN54 U2SURP RBM26 SRP14 DIDO1 ZNF217 CHEK1 CCDC7 PCF11 LENG8 BPTF LIG3 NOP58 BRCA1 FRG1 ZBTB21 MKI67 SAFB2 SPEN TP53BP1 FOXC1 | 1.21e-05 | 1245 | 187 | 28 | int:CEBPA |
| Interaction | TCF21 interactions | 1.55e-05 | 17 | 187 | 4 | int:TCF21 | |
| Interaction | NHLH1 interactions | 1.78e-05 | 88 | 187 | 7 | int:NHLH1 | |
| Interaction | NPIPB6 interactions | 1.98e-05 | 18 | 187 | 4 | int:NPIPB6 | |
| Interaction | SIRT7 interactions | FLNC RANBP2 ZC3H13 SMCHD1 U2SURP UBR4 NSD1 PSMC2 DIDO1 LARP4 BPTF NOP58 ATAD2B SYNE2 MKI67 DOCK7 PARN SPEN TP53BP1 PCNT | 2.06e-05 | 744 | 187 | 20 | int:SIRT7 |
| Interaction | H2BC8 interactions | ZEB1 SMCHD1 CHAF1A LIN54 NSD1 DIDO1 BPTF LIG3 TRMT6 YJU2 BRCA1 FRG1 MKI67 PINX1 PHF14 SPEN FOXC1 | 2.78e-05 | 576 | 187 | 17 | int:H2BC8 |
| Interaction | DCLRE1A interactions | 3.10e-05 | 20 | 187 | 4 | int:DCLRE1A | |
| Interaction | RGPD5 interactions | 3.15e-05 | 96 | 187 | 7 | int:RGPD5 | |
| Interaction | H3C1 interactions | SMCHD1 CHAF1A U2SURP UBR4 KAT6A NSD1 PSMC2 SRP14 DIDO1 BPTF LIG3 FRG1 MKI67 PINX1 UGGT2 PARN PRR14L KAT6B CABIN1 SPEN DNAH9 TP53BP1 | 3.38e-05 | 901 | 187 | 22 | int:H3C1 |
| Interaction | SUMO2 interactions | RANBP2 RNF168 SMCHD1 CHAF1A UBR4 RNF213 DIDO1 BPTF NOP58 BRCA1 ZBTB21 MKI67 SAFB2 PARN ZCCHC7 USPL1 TP53BP1 | 3.84e-05 | 591 | 187 | 17 | int:SUMO2 |
| Interaction | RANGAP1 interactions | PMS1 RGPD2 RANBP2 CLASP1 UBR4 KAT6A RGPD1 PCF11 BRCA1 USPL1 NEUROD6 RGPD5 | 3.89e-05 | 314 | 187 | 12 | int:RANGAP1 |
| Interaction | PAX6 interactions | ZEB1 SMCHD1 CHAF1A LIN54 RBM26 LARP4 TTC3 BPTF UBXN2B PBX1 CABIN1 FOXC1 PCNT | 3.95e-05 | 366 | 187 | 13 | int:PAX6 |
| Interaction | XRCC6 interactions | TCF4 ZBTB38 ZEB1 DSC1 RBBP6 SMCHD1 CHAF1A LIN54 RBM26 NSD1 DIDO1 CHEK1 CBL PCF11 BPTF LIG3 BRCA1 MKI67 SAFB2 SPEN TRIM37 TP53BP1 | 5.25e-05 | 928 | 187 | 22 | int:XRCC6 |
| Interaction | MESP2 interactions | 6.34e-05 | 9 | 187 | 3 | int:MESP2 | |
| Interaction | HAND1 interactions | 6.60e-05 | 24 | 187 | 4 | int:HAND1 | |
| Interaction | SF3A3 interactions | FLNC TCF3 SMCHD1 CHAF1A U2SURP KAT6A BRCA1 FRG1 MKI67 TADA2A SPEN FOXC1 | 8.35e-05 | 340 | 187 | 12 | int:SF3A3 |
| Interaction | ZNF677 interactions | 1.07e-04 | 27 | 187 | 4 | int:ZNF677 | |
| Interaction | SMARCA4 interactions | TCF3 ZEB1 CHAF1A KAT6A CHEK1 TTC3 BPTF BRCA1 GLI3 TMF1 NKX2-5 PBX1 CABIN1 FOXC1 | 1.10e-04 | 462 | 187 | 14 | int:SMARCA4 |
| Interaction | ASF1A interactions | ZC3H13 CHAF1A LIN54 NSD1 ANKLE2 LENG8 BRCA1 PHF14 CABIN1 SPEN | 1.16e-04 | 249 | 187 | 10 | int:ASF1A |
| Interaction | KIF18A interactions | 1.19e-04 | 52 | 187 | 5 | int:KIF18A | |
| Interaction | RASGRP1 interactions | 1.23e-04 | 11 | 187 | 3 | int:RASGRP1 | |
| Interaction | ARL16 interactions | 1.23e-04 | 83 | 187 | 6 | int:ARL16 | |
| Interaction | APEX1 interactions | TCF3 TUT4 ZEB1 SMCHD1 CHAF1A LIN54 KAT6A SANBR NSD1 DIDO1 ST3GAL4 PTPRU LARP4 TTC3 LENG8 BPTF LIG3 RASGRP1 RNF220 NOP58 BRCA1 TRMT44 PINX1 TP53BP1 FOXC1 MSLN | 1.23e-04 | 1271 | 187 | 26 | int:APEX1 |
| Interaction | CALM2 interactions | 1.35e-04 | 206 | 187 | 9 | int:CALM2 | |
| Interaction | UBE2L3 interactions | 1.62e-04 | 211 | 187 | 9 | int:UBE2L3 | |
| Interaction | TCF23 interactions | 1.63e-04 | 12 | 187 | 3 | int:TCF23 | |
| Interaction | PEA15 interactions | 1.92e-04 | 90 | 187 | 6 | int:PEA15 | |
| Interaction | NEUROD4 interactions | 2.10e-04 | 13 | 187 | 3 | int:NEUROD4 | |
| Interaction | TAL2 interactions | 2.10e-04 | 13 | 187 | 3 | int:TAL2 | |
| Interaction | TCF15 interactions | 2.10e-04 | 13 | 187 | 3 | int:TCF15 | |
| Interaction | TLE3 interactions | KDM3A MYH3 TCF4 TCF3 TCF12 VEZF1 RBBP6 ZNF217 CBL NKX2-5 SPEN FOXC1 | 2.13e-04 | 376 | 187 | 12 | int:TLE3 |
| Interaction | HDAC1 interactions | RANBP2 ZEB1 EFCAB6 CHAF1A UBR4 PSMC2 ZDBF2 ZNF217 BPTF BRCA1 GLI3 SYNE2 ZBTB21 MKI67 DOCK7 TMF1 NKX2-5 PHF14 TADA2A PBX1 CABIN1 SPEN PCNT | 2.53e-04 | 1108 | 187 | 23 | int:HDAC1 |
| Interaction | LINC02910 interactions | 2.58e-04 | 95 | 187 | 6 | int:LINC02910 | |
| Interaction | ASCL3 interactions | 2.65e-04 | 14 | 187 | 3 | int:ASCL3 | |
| Interaction | HAND2 interactions | 2.68e-04 | 34 | 187 | 4 | int:HAND2 | |
| Interaction | UBE2E2 interactions | 2.73e-04 | 96 | 187 | 6 | int:UBE2E2 | |
| Interaction | H2BC21 interactions | RNF168 SMCHD1 CHAF1A KAT6A NSD1 DIDO1 FAM47B CBL LENG8 BPTF LIG3 BRCA1 MKI67 SAFB2 INTS9 PHF14 KAT6B | 2.75e-04 | 696 | 187 | 17 | int:H2BC21 |
| Interaction | CETN1 interactions | 2.96e-04 | 63 | 187 | 5 | int:CETN1 | |
| Interaction | EWSR1 interactions | PMS1 MIA3 ZEB1 RNF168 RBBP6 CHAF1A KAT6A ANO1 ZNF217 ITGB3 CCDC7 PCF11 CAPN13 BRCA1 MKI67 SAFB2 NKX2-5 TRIM37 TP53BP1 FOXC1 | 3.00e-04 | 906 | 187 | 20 | int:EWSR1 |
| Interaction | CCDC74A interactions | 3.00e-04 | 35 | 187 | 4 | int:CCDC74A | |
| Interaction | SLX4 interactions | PMS1 RANBP2 TCF12 DSC1 SMCHD1 RBM26 DIDO1 NOP58 BRCA1 SLF2 RGPD3 ZBTB21 MKI67 CORO7 TP53BP1 | 3.01e-04 | 572 | 187 | 15 | int:SLX4 |
| Interaction | TRIM33 interactions | TCF4 RANBP2 TCF3 TCF12 U2SURP CHEK1 LARP4 BPTF NLGN3 BRCA1 TRIM37 UNC80 TP53BP1 | 3.28e-04 | 453 | 187 | 13 | int:TRIM33 |
| Interaction | MSC interactions | 3.29e-04 | 15 | 187 | 3 | int:MSC | |
| Interaction | IFI27L1 interactions | 3.43e-04 | 65 | 187 | 5 | int:IFI27L1 | |
| Interaction | RAD18 interactions | FLNC RBBP6 ZC3H13 RBM26 SRP14 LENG8 BPTF NOP58 BRCA1 SLF2 SAFB2 SPEN TP53BP1 | 3.56e-04 | 457 | 187 | 13 | int:RAD18 |
| Interaction | NUP50 interactions | PMS1 KDM3A RANBP2 ZEB1 RGPD8 RBBP6 RBM26 NSD1 YJU2 SPEN TP53BP1 | 3.57e-04 | 341 | 187 | 11 | int:NUP50 |
| Interaction | MECP2 interactions | FLNC RANBP2 ZBTB38 VEZF1 CLASP1 RBBP6 ZC3H13 U2SURP NSD1 SRP14 DIDO1 SPOCK2 PCF11 LENG8 BPTF LIG3 NOP58 FRG1 MKI67 DOCK7 SAFB2 PHF14 SPEN TP53BP1 FOXC1 | 3.68e-04 | 1287 | 187 | 25 | int:MECP2 |
| Interaction | AR interactions | KDM3A TCF4 EFCAB6 SMCHD1 LIN54 U2SURP RBM26 NSD1 PSMC2 RNF213 DIDO1 ZNF217 PCF11 CNBP LENG8 LIG3 BRCA1 GLI3 ZBTB21 TMF1 FGR | 3.69e-04 | 992 | 187 | 21 | int:AR |
| Interaction | IFI16 interactions | RGPD8 HSPA4L SMCHD1 U2SURP RNF213 LARP4 LIG3 NOP58 TRMT6 BRCA1 RGPD3 MKI67 DOCK7 SAFB2 PINX1 PHF14 TP53BP1 | 3.69e-04 | 714 | 187 | 17 | int:IFI16 |
| Interaction | DUSP16 interactions | 3.83e-04 | 237 | 187 | 9 | int:DUSP16 | |
| Interaction | PTF1A interactions | 4.03e-04 | 16 | 187 | 3 | int:PTF1A | |
| Interaction | FERD3L interactions | 4.03e-04 | 16 | 187 | 3 | int:FERD3L | |
| Interaction | VEGFD interactions | 4.14e-04 | 38 | 187 | 4 | int:VEGFD | |
| Interaction | ETV6 interactions | 4.43e-04 | 105 | 187 | 6 | int:ETV6 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.12e-06 | 115 | 133 | 8 | 769 | |
| GeneFamily | Ring finger proteins | RNF168 MARCHF10 CBLC RNF213 TRIM39 TTC3 CBL CNBP RNF220 BRCA1 TRIM37 | 6.04e-06 | 275 | 133 | 11 | 58 |
| GeneFamily | PHD finger proteins | 5.31e-05 | 90 | 133 | 6 | 88 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 7.95e-04 | 25 | 133 | 3 | 74 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PMS1 KDM3A RANBP2 TUT4 ZEB1 TCF12 VEZF1 CLASP1 SMCHD1 U2SURP KAT6A LARP4 ANKLE2 PCF11 BPTF BRCA1 MTIF2 ATAD2B SYNE2 PHF14 PARN KAT6B SPEN TRIM37 TP53BP1 PCNT PLCE1 | 1.12e-10 | 856 | 188 | 27 | M4500 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 7.06e-10 | 43 | 188 | 8 | MM3857 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MYO1G RANBP2 TUT4 ZBTB38 ZEB1 VEZF1 RBBP6 STK17A SMCHD1 U2SURP MGAT4A UBR4 DCP2 KAT6A RBM26 DOCK10 NSD1 RNF213 SPOCK2 ZNF217 CBL ANKLE2 PCF11 CNBP BPTF RASGRP1 FAM111A SLF2 TMF1 GPR171 AP4B1 KAT6B SPEN HECA | 1.91e-09 | 1492 | 188 | 34 | M40023 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD4 RGPD2 RANBP2 ZEB1 RGPD8 CLASP1 RBBP6 STK17A RGPD1 SPOCK2 ANKLE2 FBXO16 ATAD2B RGPD3 ZBTB21 KAT6B HECA RGPD5 | 1.07e-08 | 474 | 188 | 18 | M40991 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.19e-07 | 33 | 188 | 6 | MM477 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | KDM3A RANBP2 TUT4 ZEB1 RGPD8 RBBP6 U2SURP SPOCK2 ZDBF2 LENG8 NOP58 USPL1 KAT6B HECA RGPD5 | 5.89e-07 | 432 | 188 | 15 | M41149 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | THAP5 PCSK1 KDM3A RANBP2 MIA3 ZBTB38 HSPA4L U2SURP MGAT4A DOCK10 CASR TTC3 CAPN13 CNBP RASGRP1 CADPS SYNE2 PNMA8A KAT6B TRIM37 UNC80 VEGFB | 1.32e-06 | 946 | 188 | 22 | M39169 |
| Coexpression | GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP | TCF4 TCF3 RBBP6 STK17A SMCHD1 KAT6A SPOCK2 CD83 PCF11 RASGRP1 | 1.42e-06 | 193 | 188 | 10 | M4961 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | PMS1 TUT4 TCF12 CLASP1 SMCHD1 U2SURP KAT6A LARP4 BPTF BRCA1 ATAD2B PARN KAT6B SPEN TRIM37 | 1.51e-06 | 466 | 188 | 15 | M13522 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | PMS1 TUT4 CLASP1 KAT6A DIDO1 ZNF217 PCF11 BPTF MTIF2 MKI67 KAT6B SPEN | 1.92e-06 | 300 | 188 | 12 | M8702 |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP | FILIP1 TUT4 DCP2 DOCK10 ZNF217 TTC3 NLGN3 SLFN13 GPR171 HECA | 1.96e-06 | 200 | 188 | 10 | M8954 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | THAP5 PMS1 RANBP2 ZBTB38 TCF12 VEZT U2SURP MGAT4A DOCK10 PSMC2 SLC39A10 ERLEC1 RASGRP1 NOP58 ZBTB21 TMF1 PHF14 ZCCHC7 | 2.51e-06 | 687 | 188 | 18 | M41022 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | RGPD4 RGPD2 TCF4 RANBP2 ZEB1 RGPD8 VEZT MGAT4A DCP2 KAT6A RGPD1 CD83 SLFN13 RGPD3 | 3.42e-06 | 435 | 188 | 14 | MM1221 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TCF4 TUT4 ZBTB38 HSPA4L ADAM9 SMCHD1 MGAT4A RBM26 DOCK10 ZNF354B BPTF FAM111A BRCA1 SYNE2 MKI67 TMF1 DNAJC1 | 5.58e-06 | 656 | 188 | 17 | M18979 |
| Coexpression | GU_PDEF_TARGETS_UP | 1.22e-05 | 71 | 188 | 6 | M3955 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | KDM3A RANBP2 ZBTB38 ZEB1 CLASP1 STK17A MGAT4A TTC3 SYNE2 USPL1 KAT6B RGPD5 | 1.33e-05 | 363 | 188 | 12 | M41103 |
| Coexpression | GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN | 1.45e-05 | 199 | 188 | 9 | M3517 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 1.50e-05 | 200 | 188 | 9 | M9341 | |
| Coexpression | GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN | 1.50e-05 | 200 | 188 | 9 | M3508 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | SMCHD1 CHEK1 SLC39A10 TTC3 ANKLE2 CEP164 TRMT6 IFTAP BRCA1 PHF14 PRR14L TRIM37 TP53BP1 | 1.65e-05 | 434 | 188 | 13 | M15150 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | SMCHD1 CHEK1 SLC39A10 TTC3 ANKLE2 CEP164 TRMT6 IFTAP BRCA1 PHF14 PRR14L TRIM37 TP53BP1 | 2.30e-05 | 448 | 188 | 13 | MM1044 |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP | 3.28e-05 | 170 | 188 | 8 | M6697 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | KDM3A RANBP2 ZEB1 RGPD8 RBBP6 STK17A KAT6A RBM26 TRMO SPOCK2 ZDBF2 FBXO16 NOP58 ANGEL2 TMF1 RGPD5 | 3.44e-05 | 680 | 188 | 16 | M41089 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 4.75e-05 | 90 | 188 | 6 | M39250 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | PMS1 FRAS1 TCF12 U2SURP CHEK1 LARP4 CFI GFER RGS12 NOP58 TRMT6 BRCA1 MKI67 TRIM37 | 5.14e-05 | 555 | 188 | 14 | M2343 |
| Coexpression | BROWNE_HCMV_INFECTION_12HR_DN | 8.57e-05 | 100 | 188 | 6 | M5775 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 9.61e-05 | 198 | 188 | 8 | M8624 | |
| Coexpression | GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN | 1.03e-04 | 200 | 188 | 8 | M391 | |
| Coexpression | GSE28237_EARLY_VS_LATE_GC_BCELL_DN | 1.03e-04 | 200 | 188 | 8 | M4894 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 1.03e-04 | 200 | 188 | 8 | M6096 | |
| Coexpression | GSE3039_CD4_TCELL_VS_NKT_CELL_UP | 1.03e-04 | 200 | 188 | 8 | M6426 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN | 1.03e-04 | 200 | 188 | 8 | M6247 | |
| Coexpression | GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN | 1.03e-04 | 200 | 188 | 8 | M6943 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP | 1.13e-04 | 66 | 188 | 5 | M1752 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.21e-04 | 323 | 188 | 10 | M9150 | |
| Coexpression | GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP | 1.62e-04 | 160 | 188 | 7 | M6863 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | PMS1 RANBP2 FRAS1 TCF3 TCF12 CLASP1 VEZT CXCL10 CHAF1A U2SURP RNF213 ZDBF2 CHEK1 SLC39A10 ANKLE2 NOP58 UBXN2B BRCA1 ANGEL2 MKI67 DOCK7 PINX1 PHF14 | 1.98e-04 | 1407 | 188 | 23 | M14427 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.04e-04 | 221 | 188 | 8 | M39222 | |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP | 2.24e-04 | 224 | 188 | 8 | M12383 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN | 2.43e-04 | 171 | 188 | 7 | M8820 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | PMS1 TCF3 TUT4 ZEB1 TCF12 VEZF1 CLASP1 HSPA4L ZC3H13 CHAF1A LIN54 RBM26 SANBR NSD1 ZDBF2 ARMCX4 TTC3 FBXO16 BPTF NLGN3 ORM2 BRCA1 CADPS SYNE2 MKI67 DOCK7 PHF14 MDGA1 PEA15 TRIM37 TP53BP1 PLCE1 | 3.33e-07 | 1370 | 186 | 32 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | PMS1 TUT4 ZEB1 TCF12 RNF168 CLASP1 RBBP6 ZC3H13 SMCHD1 LIN54 RBM26 SANBR NSD1 CBLC ZDBF2 BPTF NOP58 TRMT6 BRCA1 MTIF2 GLI3 ATAD2B SYNE2 MKI67 DOCK7 PINX1 PHF14 DNAJC1 TRIM37 TP53BP1 | 5.24e-07 | 1257 | 186 | 30 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | CLASP1 HSPA4L ZC3H13 RBM26 PCDHB9 ANO1 RNF213 CHEK1 PEX11A LARP4 FRMD4B HSF5 RASGRP1 SYCP2 ADAMTS9 SYNE2 UGGT2 DNAJC1 ZCCHC7 LRRC17 TDRP TDRD12 | 1.36e-06 | 778 | 186 | 22 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | RANBP2 RNF168 MARCHF10 EFCAB6 HSPA4L RBBP6 CHAF1A SANBR ANO1 ZDBF2 NLGN1 PTPRU LARP4 BRCA1 GLI3 ATAD2B SYNE2 TMF1 PHF14 GPR171 DNAJC1 MARVELD2 KAT6B LRRC17 PCNT | 1.69e-06 | 983 | 186 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | PMS1 TUT4 ZEB1 TCF12 RNF168 CLASP1 HSPA4L RBBP6 ZC3H13 SMCHD1 LIN54 RBM26 SANBR NSD1 CBLC ZDBF2 BPTF NOP58 TRMT6 BRCA1 MTIF2 GLI3 ATAD2B SYNE2 MKI67 DOCK7 PINX1 PHF14 DNAJC1 TRIM37 TP53BP1 | 3.81e-06 | 1459 | 186 | 31 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RANBP2 ZBTB38 RNF168 RBBP6 LIN54 SANBR TRIM39 ZDBF2 NLGN1 ARMCX4 ERLEC1 CEP164 IFTAP BRCA1 MTIF2 GLI3 SYNE2 MKI67 SAFB2 PHF14 PRR14L DNAJC1 | 3.97e-06 | 831 | 186 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | ZEB1 HSPA4L BAG5 SANBR ZDBF2 FRMD4B MTIF2 SYNE2 PEA15 TRIM37 TP53BP1 | 4.99e-06 | 225 | 186 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | ZC3H13 RBM26 CHEK1 LARP4 FRMD4B RASGRP1 SYCP2 ADAMTS9 SYNE2 DNAJC1 ZCCHC7 TDRP KLHL4 TDRD12 | 7.37e-06 | 382 | 186 | 14 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | RANBP2 RNF168 MARCHF10 EFCAB6 HSPA4L CHAF1A SANBR ANO1 ZDBF2 NLGN1 LARP4 BRCA1 GLI3 SYNE2 GPR171 DNAJC1 | 7.56e-06 | 493 | 186 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | TUT4 ZBTB38 RNF168 RBBP6 LIN54 TRIM39 ARMCX4 ERLEC1 CEP164 IFTAP BRCA1 ATAD2B SYNE2 MKI67 DOCK7 SAFB2 UGGT2 PHF14 PRR14L ZCCHC7 | 1.78e-05 | 780 | 186 | 20 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TUT4 ZEB1 TCF12 CLASP1 ZC3H13 LIN54 SANBR ZDBF2 NLGN1 FRMD4B CAPN13 UBXN2B BRCA1 CADPS MTIF2 GLI3 ATAD2B SYNE2 MKI67 DOCK7 PHF14 MDGA1 TRIM37 TP53BP1 | 1.94e-05 | 1060 | 186 | 24 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | RANBP2 TUT4 RNF168 RBBP6 NOP58 BRCA1 MTIF2 GLI3 ATAD2B SYNE2 MKI67 PHF14 | 2.03e-05 | 311 | 186 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.85e-05 | 137 | 186 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K4 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | KDM3A TCF4 TUT4 ZBTB38 TCF12 HSPA4L RBBP6 U2SURP PCDHB10 PCDHB9 SPOCK2 ZDBF2 PTPRU CCDC39 RGS12 FBXO16 BPTF SERPINB10 IFTAP GLI3 PNMA8A DNAJC1 AP4B1 PBX1 KAT6B TDRP | 3.40e-05 | 1245 | 186 | 26 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | RANBP2 RNF168 SANBR ZDBF2 NLGN1 BRCA1 GLI3 SYNE2 GPR171 DNAJC1 | 3.99e-05 | 232 | 186 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | KDM3A FLNC FRAS1 TUT4 ZCWPW1 TCF12 DOCK10 RNF213 ZDBF2 FRMD4B PCF11 FAM111A SLF2 GLI3 TADA2A PBX1 KAT6B PLCE1 KLHL4 FOXC2 | 4.35e-05 | 831 | 186 | 20 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | FLNC TUT4 ZCWPW1 DOCK10 RNF213 ZDBF2 ST3GAL4 CHEK1 FRMD4B FAM111A ADAMTS9 SLF2 CADPS SLFN13 SYNE2 DOCK7 LRRC17 PLCE1 KLHL4 | 4.73e-05 | 768 | 186 | 19 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.11e-05 | 192 | 186 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.70e-05 | 151 | 186 | 8 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RANBP2 RNF168 RBBP6 SANBR ZDBF2 NLGN1 PTPRU LARP4 BRCA1 GLI3 SYNE2 TMF1 PHF14 GPR171 DNAJC1 KAT6B PCNT | 6.61e-05 | 654 | 186 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | PMS1 ZEB1 RNF168 SMCHD1 BAG5 KAT6A SANBR DIDO1 ZDBF2 FRMD4B BPTF MTIF2 ATAD2B SYNE2 MKI67 TRIM37 | 7.36e-05 | 595 | 186 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | CLASP1 ZC3H13 RBM26 ANO1 RNF213 DIDO1 PEX11A LARP4 FRMD4B HSF5 RASGRP1 SYCP2 IFTAP ADAMTS9 SYNE2 UGGT2 DNAJC1 ZCCHC7 TDRP | 7.49e-05 | 795 | 186 | 19 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | TCF3 CLASP1 HSPA4L BAG5 ZDBF2 FRMD4B SYNE2 DNAJC1 SPEN TRIM37 TP53BP1 | 1.07e-04 | 314 | 186 | 11 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | FILIP1 TUT4 ZEB1 TCF12 CLASP1 HSPA4L ZC3H13 LIN54 SANBR ZDBF2 NLGN1 FRMD4B CAPN13 UBXN2B BRCA1 CADPS MTIF2 GLI3 ATAD2B SYNE2 MKI67 DOCK7 PHF14 MDGA1 TRIM37 TP53BP1 TDRP | 1.09e-04 | 1414 | 186 | 27 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | KDM3A FLNC ZCWPW1 CHAF1A DOCK10 RNF213 ZDBF2 ST3GAL4 FRMD4B FAM111A ADAMTS9 SLF2 GLI3 SYNE2 TADA2A LRRC17 PLCE1 KLHL4 FOXC2 | 1.25e-04 | 827 | 186 | 19 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | RANBP2 RNF168 RBBP6 SANBR ZDBF2 NLGN1 BRCA1 SYNE2 GPR171 DNAJC1 KAT6B | 1.57e-04 | 328 | 186 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | RANBP2 TUT4 RNF168 HSPA4L RBBP6 U2SURP SANBR ZDBF2 NLGN1 LARP4 NOP58 TRMT6 BRCA1 MTIF2 GLI3 ATAD2B SYNE2 MKI67 PHF14 DNAJC1 PCNT | 1.63e-04 | 989 | 186 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | ZC3H13 RNF213 LARP4 FRMD4B RASGRP1 SYCP2 IFTAP ADAMTS9 SYNE2 DNAJC1 ZCCHC7 TDRP | 1.64e-04 | 387 | 186 | 12 | gudmap_developingGonad_e16.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | HSPA4L ZC3H13 RBM26 RNF213 CHEK1 LARP4 FRMD4B RASGRP1 SYCP2 IFTAP BRCA1 ADAMTS9 SYNE2 DNAJC1 ZCCHC7 TDRP KLHL4 TDRD12 | 1.69e-04 | 776 | 186 | 18 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | CLASP1 ZC3H13 RBM26 PCDHB9 ANO1 CBL FRMD4B ADAMTS9 SYNE2 DNAJC1 LRRC17 KLHL4 | 2.98e-04 | 413 | 186 | 12 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_500 | 4.07e-04 | 40 | 186 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ZEB1 RNF168 BAG5 KAT6A RBM26 SANBR DIDO1 NLGN1 BPTF SLF2 MTIF2 GLI3 ATAD2B SYNE2 MKI67 | 4.47e-04 | 629 | 186 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.44e-04 | 210 | 186 | 8 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | TCF4 TUT4 ZEB1 STK17A SMCHD1 SPOCK2 RASGRP1 NOP58 SYNE2 TMF1 RGPD5 | 7.99e-10 | 195 | 189 | 11 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | RGPD2 ZBTB38 STK17A SMCHD1 SPOCK2 RASGRP1 NOP58 FAM111A SYNE2 FRMPD3 | 1.25e-08 | 196 | 189 | 10 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | TUT4 ZEB1 STK17A SMCHD1 RNF213 SPOCK2 RASGRP1 NOP58 SYNE2 GPR171 | 1.45e-08 | 199 | 189 | 10 | 952fac67588ad5676f5939e3c7f8bac803c27064 |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-07 | 191 | 189 | 9 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.40e-07 | 192 | 189 | 9 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 1.47e-07 | 193 | 189 | 9 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-07 | 195 | 189 | 9 | e06ff785c5542c86c335d956799e03f7ae8345a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-07 | 196 | 189 | 9 | c225c8eb2fe9a10f0cf574c7d8b6206887aac2df | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.90e-07 | 199 | 189 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.90e-07 | 199 | 189 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 184 | 189 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-06 | 190 | 189 | 8 | 05e6af222d0ad97cb69f399a96c9038f9dd989b9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-06 | 191 | 189 | 8 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.64e-06 | 191 | 189 | 8 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.64e-06 | 191 | 189 | 8 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-06 | 191 | 189 | 8 | 142f98cabf8737b28369315b3d7a0797ded88e03 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-06 | 191 | 189 | 8 | 2b427741a58921e161101a282d1fe526cd9e760d | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 1.71e-06 | 192 | 189 | 8 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-06 | 192 | 189 | 8 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.71e-06 | 192 | 189 | 8 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.71e-06 | 192 | 189 | 8 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.78e-06 | 193 | 189 | 8 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-06 | 194 | 189 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 1.85e-06 | 194 | 189 | 8 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.92e-06 | 195 | 189 | 8 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 1.99e-06 | 196 | 189 | 8 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.99e-06 | 196 | 189 | 8 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.07e-06 | 197 | 189 | 8 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-06 | 197 | 189 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.07e-06 | 197 | 189 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19_Moderate-CD8+_Tem|World / disease group, cell group and cell class | 2.15e-06 | 198 | 189 | 8 | 1d12be256af028c88e31fb535068bae16b7bd48e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.15e-06 | 198 | 189 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-06 | 198 | 189 | 8 | a3bd099ef0e606c2da690a6fcf6f79e9360c9c9f | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.23e-06 | 199 | 189 | 8 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.23e-06 | 199 | 189 | 8 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.23e-06 | 199 | 189 | 8 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.23e-06 | 199 | 189 | 8 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.23e-06 | 199 | 189 | 8 | 3003badee037d4d63a8018a74c0aea213d049e43 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.32e-06 | 200 | 189 | 8 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.32e-06 | 200 | 189 | 8 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.32e-06 | 200 | 189 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 2.32e-06 | 200 | 189 | 8 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.32e-06 | 200 | 189 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 2.32e-06 | 200 | 189 | 8 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.32e-06 | 200 | 189 | 8 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.13e-06 | 166 | 189 | 7 | fb2cfbf1d0a0f1950dd24c08ba00ebd64b06ceb4 | |
| ToppCell | 343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.13e-06 | 166 | 189 | 7 | a54377c703efff42d2cc1a8fdb610facc58053dd | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.02e-06 | 169 | 189 | 7 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.02e-06 | 169 | 189 | 7 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.66e-06 | 171 | 189 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.99e-06 | 172 | 189 | 7 | eee45759284baa3ed77da6a5fbcc4f8f6c553106 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-MAIT|Int-URO / Disease, Lineage and Cell Type | 9.70e-06 | 174 | 189 | 7 | 5227ed29f5f0d3e0aaa7f3cfd362f96d3e2660f7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.04e-05 | 176 | 189 | 7 | 856a8c4211ea33d926b18d8959a03909562aa563 | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.08e-05 | 177 | 189 | 7 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 178 | 189 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-05 | 178 | 189 | 7 | f94e306b9550f3d1b5de0bb806790c17823d439e | |
| ToppCell | COPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 1.21e-05 | 180 | 189 | 7 | 51a12fbad5fa7bb12e6d616a02ff9b5141e2b063 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-05 | 180 | 189 | 7 | 5bf5878be3230d38c8e65fb954f326d567e1b520 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 182 | 189 | 7 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 183 | 189 | 7 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.44e-05 | 185 | 189 | 7 | f1263899a2d41d182022dc4ca62cbae08a463c89 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.44e-05 | 185 | 189 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 186 | 189 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-05 | 186 | 189 | 7 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 187 | 189 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-05 | 188 | 189 | 7 | ecc2364d946f97ae0212fd6739960c9fc75e4919 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.60e-05 | 188 | 189 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19-kidney-T-cells-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.60e-05 | 188 | 189 | 7 | 15484c05cb496cd98ed3f79a6134c5cec8f09a4d | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.66e-05 | 189 | 189 | 7 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17|Lung / Manually curated celltypes from each tissue | 1.66e-05 | 189 | 189 | 7 | f43960506ed3e699e910ec7711c1113e2e9b80d1 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-05 | 189 | 189 | 7 | d05e043d0874b8563b9f5514f6c884b35c603e3a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.71e-05 | 190 | 189 | 7 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 1.71e-05 | 190 | 189 | 7 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 1.71e-05 | 190 | 189 | 7 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.71e-05 | 190 | 189 | 7 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-05 | 190 | 189 | 7 | 69c5c4d5f4fb6e5ae2c9dbf9d209faf093c3f769 | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|Control / Disease state, Lineage and Cell class | 1.77e-05 | 191 | 189 | 7 | 03b5c5e0941c3402ab3f48cbf3da2a027d110421 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.77e-05 | 191 | 189 | 7 | 752e31a4b8aab9243b0451f4c40c2940ae9a5252 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.77e-05 | 191 | 189 | 7 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-05 | 191 | 189 | 7 | 82f4a4b0c35638ca4b2c428d0bb946ea95c1001b | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4|Lung / Manually curated celltypes from each tissue | 1.83e-05 | 192 | 189 | 7 | fd19cd0b5330448bef8debd753285adbc8b958a2 | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.83e-05 | 192 | 189 | 7 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-05 | 192 | 189 | 7 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.83e-05 | 192 | 189 | 7 | 71bc03b08cda0382ea45b503d5f4f135ed98cc11 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.90e-05 | 193 | 189 | 7 | 326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.90e-05 | 193 | 189 | 7 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | IIH-CD8|IIH / Condition, Cell_class and T cell subcluster | 1.90e-05 | 193 | 189 | 7 | 343ac8c6dc6d7c7a944a14de65f1d4ea3dfafe86 | |
| ToppCell | IPF-Lymphoid|IPF / Disease state, Lineage and Cell class | 1.90e-05 | 193 | 189 | 7 | bf9d50aea909a28dd1d0933af33842d5f1ae7818 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.90e-05 | 193 | 189 | 7 | 00349d176fb6a46cbcc99c41d975651b6e9aaad4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.96e-05 | 194 | 189 | 7 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | Control-Lymphoid|Control / Disease state, Lineage and Cell class | 1.96e-05 | 194 | 189 | 7 | d5b124f15c953eeb7e8e990df44d7fa466f2b31f | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-05 | 194 | 189 | 7 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | severe_COVID-19-CD4+_CTL|World / disease group, cell group and cell class (v2) | 1.96e-05 | 194 | 189 | 7 | bdafc1173b7b8cde8714573fbeee5394a2484a5f | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.96e-05 | 194 | 189 | 7 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.03e-05 | 195 | 189 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-05 | 195 | 189 | 7 | 31b011f3d54e6729802aad1f771cef77744e3ff2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.03e-05 | 195 | 189 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 195 | 189 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.09e-05 | 196 | 189 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.09e-05 | 196 | 189 | 7 | c06caba0c91b8ee66f42bc43ec75eb2475f07056 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.26e-06 | 177 | 188 | 10 | 985_DN | |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; HL60; HT_HG-U133A | 4.90e-06 | 193 | 188 | 10 | 2731_UP | |
| Drug | FK-506; Up 200; 1uM; MCF7; HG-U133A | TCF3 TRMO PEX11A AXIN1 LIG3 SERPINB10 GRAMD2B PBX1 CABIN1 VEGFB | 5.88e-06 | 197 | 188 | 10 | 284_UP |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; HL60; HT_HG-U133A | 6.15e-06 | 198 | 188 | 10 | 2425_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.49e-05 | 174 | 188 | 9 | 6493_DN | |
| Disease | Pitt-Hopkins syndrome (implicated_via_orthology) | 2.20e-07 | 3 | 179 | 3 | DOID:0060488 (implicated_via_orthology) | |
| Disease | Chromosome 5, monosomy 5q35 | 3.66e-05 | 2 | 179 | 2 | C2931574 | |
| Disease | obesity (implicated_via_orthology) | 5.36e-05 | 215 | 179 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 7.25e-05 | 166 | 179 | 7 | EFO_0004530, EFO_0004611 | |
| Disease | Dystrophia myotonica 2 | 1.09e-04 | 3 | 179 | 2 | C2931689 | |
| Disease | Congenital Myotonic Dystrophy | 1.09e-04 | 3 | 179 | 2 | C0410226 | |
| Disease | N-palmitoyl-sphinganine (d18:0/16:0) measurement | 1.09e-04 | 3 | 179 | 2 | EFO_0800428 | |
| Disease | Myotonic Dystrophy | 1.09e-04 | 3 | 179 | 2 | C0027126 | |
| Disease | Tetralogy of Fallot | 1.16e-04 | 16 | 179 | 3 | C0039685 | |
| Disease | mean platelet volume | ZBTB38 TCF12 U2SURP DOCK10 TRMO CASR ST3GAL4 ZNF217 ITGB3 RGS12 NLRP6 TRABD ATAD2B SYNE2 DOCK7 PBX1 PLCE1 | 1.69e-04 | 1020 | 179 | 17 | EFO_0004584 |
| Disease | ovarian neoplasm | 1.73e-04 | 134 | 179 | 6 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 1.95e-04 | 137 | 179 | 6 | C1140680 | |
| Disease | Noonan syndrome (implicated_via_orthology) | 2.18e-04 | 4 | 179 | 2 | DOID:3490 (implicated_via_orthology) | |
| Disease | lymphocyte count | MYO1G TCF4 FRAS1 ZBTB38 LIN54 SANBR DOCK10 NSD1 ST3GAL4 ZNF217 CBL ANKLE2 ERLEC1 ATAD2B PINX1 NKX2-5 TADA2A PBX1 CORO7 PLCE1 DCAF12 | 2.30e-04 | 1464 | 179 | 21 | EFO_0004587 |
| Disease | sitting height ratio | 2.62e-04 | 51 | 179 | 4 | EFO_0007118 | |
| Disease | Fuchs Endothelial Dystrophy | 3.62e-04 | 5 | 179 | 2 | C0016781 | |
| Disease | triglycerides in LDL measurement | 3.76e-04 | 56 | 179 | 4 | EFO_0022320 | |
| Disease | serum non-albumin protein measurement | 3.81e-04 | 361 | 179 | 9 | EFO_0004568 | |
| Disease | Lynch syndrome (is_implicated_in) | 4.05e-04 | 24 | 179 | 3 | DOID:3883 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.32e-04 | 222 | 179 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.55e-04 | 224 | 179 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.55e-04 | 224 | 179 | 7 | EFO_0004574, EFO_0008317 | |
| Disease | atrial fibrillation | 4.64e-04 | 371 | 179 | 9 | EFO_0000275 | |
| Disease | serine protease inhibitor Kazal-type 2 measurement | 5.40e-04 | 6 | 179 | 2 | EFO_0802054 | |
| Disease | Fuchs' endothelial dystrophy (is_implicated_in) | 5.40e-04 | 6 | 179 | 2 | DOID:11555 (is_implicated_in) | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 5.92e-04 | 111 | 179 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | pancreatic cancer (is_implicated_in) | 6.17e-04 | 112 | 179 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 7.45e-04 | 67 | 179 | 4 | EFO_0022245 | |
| Disease | glycoprotein measurement | 8.12e-04 | 119 | 179 | 5 | EFO_0004555 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.09e-03 | 260 | 179 | 7 | EFO_0008317 | |
| Disease | pain | 1.29e-03 | 196 | 179 | 6 | EFO_0003843 | |
| Disease | colon cancer (is_implicated_in) | 1.35e-03 | 36 | 179 | 3 | DOID:219 (is_implicated_in) | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.48e-03 | 274 | 179 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | neuroblastoma (is_implicated_in) | 1.59e-03 | 10 | 179 | 2 | DOID:769 (is_implicated_in) | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.66e-03 | 206 | 179 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.73e-03 | 84 | 179 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.89e-03 | 144 | 179 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | coagulation factor XA measurement | 1.94e-03 | 11 | 179 | 2 | EFO_0020266 | |
| Disease | level of Ceramide (d40:1) in blood serum | 1.94e-03 | 11 | 179 | 2 | OBA_2045185 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.06e-03 | 215 | 179 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.07e-03 | 291 | 179 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | suicide behaviour measurement | 2.27e-03 | 43 | 179 | 3 | EFO_0006882 | |
| Disease | liver fat measurement | 2.27e-03 | 43 | 179 | 3 | EFO_0010821 | |
| Disease | triglycerides in large LDL measurement | 2.27e-03 | 43 | 179 | 3 | EFO_0022319 | |
| Disease | lean body mass | 2.29e-03 | 379 | 179 | 8 | EFO_0004995 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.31e-03 | 220 | 179 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | Mouth Diseases | 2.32e-03 | 12 | 179 | 2 | C0026636 | |
| Disease | Malignant neoplasm of breast | KDM3A ZEB1 UBR4 EFCAB13 CHEK1 TTC3 SLC22A9 BRCA1 SYNE2 MKI67 KAT6B SPEN DNAH9 TP53BP1 VEGFB | 2.39e-03 | 1074 | 179 | 15 | C0006142 |
| Disease | potassium measurement | 2.58e-03 | 45 | 179 | 3 | EFO_0009283 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.59e-03 | 225 | 179 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | unipolar depression, bipolar disorder | 2.68e-03 | 156 | 179 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | tumor necrosis factor ligand superfamily member 8 measurement | 2.73e-03 | 13 | 179 | 2 | EFO_0010592 | |
| Disease | alcohol and nicotine codependence | 2.73e-03 | 13 | 179 | 2 | EFO_0004776 | |
| Disease | coagulation factor X measurement | 2.73e-03 | 13 | 179 | 2 | EFO_0020265 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 2.73e-03 | 13 | 179 | 2 | C0238288 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.82e-03 | 229 | 179 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 3.17e-03 | 14 | 179 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 3.27e-03 | 100 | 179 | 4 | C0010606 | |
| Disease | cholesterol in medium LDL measurement | 3.30e-03 | 49 | 179 | 3 | EFO_0022224 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.30e-03 | 49 | 179 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | pancreatic cancer (is_marker_for) | 3.38e-03 | 101 | 179 | 4 | DOID:1793 (is_marker_for) | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.48e-03 | 239 | 179 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | African Burkitt's lymphoma | 3.65e-03 | 15 | 179 | 2 | C0343640 | |
| Disease | Burkitt Leukemia | 3.65e-03 | 15 | 179 | 2 | C4721444 | |
| Disease | age-related hearing impairment | 3.76e-03 | 324 | 179 | 7 | EFO_0005782 | |
| Disease | total lipids in medium LDL | 3.90e-03 | 52 | 179 | 3 | EFO_0022180 | |
| Disease | free cholesterol in small LDL measurement | 4.12e-03 | 53 | 179 | 3 | EFO_0022271 | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 4.15e-03 | 16 | 179 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | cutaneous Leishmaniasis | 4.15e-03 | 16 | 179 | 2 | EFO_0005046 | |
| Disease | Leukemia, Myelocytic, Acute | 4.17e-03 | 173 | 179 | 5 | C0023467 | |
| Disease | remnant cholesterol measurement | 4.30e-03 | 108 | 179 | 4 | EFO_0010815 | |
| Disease | Moyamoya Disease | 4.69e-03 | 17 | 179 | 2 | C0026654 | |
| Disease | free cholesterol measurement | 5.05e-03 | 113 | 179 | 4 | EFO_0008591 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 5.05e-03 | 57 | 179 | 3 | EFO_0022284 | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 5.21e-03 | 114 | 179 | 4 | EFO_0004529, EFO_0004611 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 5.21e-03 | 114 | 179 | 4 | EFO_0004574, EFO_0004611 | |
| Disease | migraine disorder, systolic blood pressure | 5.25e-03 | 18 | 179 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | Malignant neoplasm of endometrium | 5.25e-03 | 18 | 179 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 5.25e-03 | 18 | 179 | 2 | C0346191 | |
| Disease | grip strength measurement | 5.69e-03 | 350 | 179 | 7 | EFO_0006941 | |
| Disease | phospholipids in small VLDL measurement | 5.83e-03 | 60 | 179 | 3 | EFO_0022146 | |
| Disease | triglycerides to total lipids in large HDL percentage | 5.83e-03 | 60 | 179 | 3 | EFO_0022330 | |
| Disease | HMG CoA reductase inhibitor use measurement | 6.04e-03 | 189 | 179 | 5 | EFO_0009932 | |
| Disease | cancer (implicated_via_orthology) | 6.04e-03 | 268 | 179 | 6 | DOID:162 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRNAKKCLEDNKLVP | 91 | A8MVM7 | |
| LCKKVESPKKNLRES | 6 | P59817 | |
| EKAEPECLASKLREK | 191 | Q7L0X2 | |
| KPRQVTVKLKCKESD | 426 | Q96DZ1 | |
| DKTPEDVICERSKNK | 446 | Q86XL3 | |
| KKDGNKKDCELPRSI | 436 | P05156 | |
| AVDPQGEEKCKAARK | 411 | Q9UL15 | |
| CKICAESNKDVKIEP | 351 | Q9ULV8 | |
| RPEAVKSCEALAQKI | 231 | Q96M83 | |
| DMKRAVDCPENIKKE | 41 | O14757 | |
| VAVKKLEPGNCKADE | 2376 | Q8IZF6 | |
| AKDQDLKSRPESVEC | 46 | P41180 | |
| LVVFECKKRAKNPVA | 586 | O95267 | |
| DKCEPLEKQHEKERK | 181 | P19652 | |
| SEDVVKELKKALCNP | 6 | Q9Y6B7 | |
| TCDPRKSQLHKKRED | 296 | Q6MZZ7 | |
| CEKKLHPRKLQDNFE | 351 | Q8IU60 | |
| TKILGDKNVDPKCED | 146 | Q5VTE6 | |
| CADPENHKVRQKLKA | 651 | Q13111 | |
| KKLEERPVNKCSDQI | 1491 | Q12830 | |
| DKIARCVPSKSKEDC | 521 | Q96KC8 | |
| KKKCENPELSGLERI | 26 | Q7Z4U5 | |
| CPETKKARDACIIEK | 26 | Q14061 | |
| KLRALAAECNDPEVK | 2266 | Q5H9R4 | |
| REGDCLDAKINKAEK | 676 | Q9UFE4 | |
| KVEPKKCELSKNSDI | 2571 | P49792 | |
| KLKDEVKAASPGRCL | 786 | Q5T8P6 | |
| SADEKEKPCAKSRAR | 486 | Q96L73 | |
| VEPKKCELSKNSDIE | 1596 | Q99666 | |
| VEPKKCELSKNSDIE | 1596 | O14715 | |
| KKRKRVSDDVPDCKV | 566 | Q9NV88 | |
| SCAEPLSEGRKKAKK | 596 | O95453 | |
| KKQKQRPSEERICHA | 21 | Q8WYB5 | |
| VTGCPAQRKEETFKK | 126 | Q01151 | |
| IDDVTLKKGECPRKQ | 906 | Q8NFP4 | |
| SRKPCVNKEELALKK | 291 | Q86V59 | |
| KNCPDQDLKIKLAVR | 501 | Q9ULU8 | |
| PEKDAKHCDRQKANL | 336 | Q9UM21 | |
| LPTCSKKRKIEQVDK | 436 | Q9Y2X3 | |
| PSEEAKEELAKKCGI | 261 | P40424 | |
| CQKQRKKKPAEDILE | 3926 | Q86XX4 | |
| REECLQVKTVKAEKP | 686 | P10071 | |
| KAIKACLDRNPEAFK | 566 | Q6MZP7 | |
| CKKLEPVATAKEDAG | 6 | P09769 | |
| AVNKCDKAEADPEKV | 286 | P46199 | |
| GEAAEEAKKCRPPNK | 216 | Q9UBI9 | |
| TLDCKRKELKKVPNN | 251 | Q8N6Y2 | |
| RTLKQPDSVCKDKSK | 91 | Q9ULI0 | |
| LNPKAACLKRREEEK | 626 | P15884 | |
| AALECEDPERELKKQ | 496 | Q96PV6 | |
| ACKDKQLRIFDPRTK | 186 | P57737 | |
| EQLKSACKEDIPSEK | 21 | Q15121 | |
| QERVAKKKSAPAEEQ | 246 | Q96BK5 | |
| TPECRTTDQDQKIKK | 486 | Q8NA70 | |
| VEGPSKAEITCKDNK | 1896 | Q14315 | |
| PKAACLKRREEEKVS | 641 | Q99081 | |
| ASPKETKAQKEKLRC | 301 | O14626 | |
| EVEKTACPSGKKARE | 296 | Q13421 | |
| LNECFVKVPRDDKKP | 126 | Q99958 | |
| KQQSPPDHEECVKRK | 696 | Q5XXA6 | |
| VKRCAENPKKAEDNV | 3226 | P46013 | |
| PTEDVKRISKECARK | 161 | Q8N2Q7 | |
| TNEKLDREKLCGPKE | 86 | Q9UN67 | |
| KVGEKRKAADETLCQ | 916 | P49916 | |
| DPAKDPRAEKKELCA | 101 | P52952 | |
| PRAEKKELCALQKAV | 106 | P52952 | |
| GKEKVLEDCQLPKVD | 2051 | O95613 | |
| KPKAEDLRTECATCK | 861 | O94880 | |
| PEKNLFKEACEKRAQ | 111 | Q9C0H6 | |
| EETKSVDKNPCKDRE | 1556 | Q7Z6E9 | |
| VDKNPCKDREKHVLE | 1561 | Q7Z6E9 | |
| KPRDGNEEECAVKKS | 41 | P0DTF9 | |
| KAACKESKRPLEVSQ | 726 | Q92729 | |
| PSSKCEQEELEKQKL | 211 | P17481 | |
| KNELQEPCDSPKVKE | 1511 | O94913 | |
| FCLGTKEQNREKKPE | 211 | Q92794 | |
| KEQNREKKPEELISC | 216 | Q92794 | |
| EDVKRISKECARKPN | 151 | Q9NZ94 | |
| KVEPKKCELSKNSDI | 1596 | A6NKT7 | |
| TEKKVDLNADPLCER | 336 | P38398 | |
| RSCAERETKKKDDIP | 181 | Q14331 | |
| AAKKLANEPDLCKTV | 516 | Q9Y2L6 | |
| PQNCKEVKRLKGASE | 1736 | Q9P2N4 | |
| EKEQKPRKKTQTCDT | 1096 | B1AJZ9 | |
| KELCKQQKRKDTSPD | 201 | Q86VG3 | |
| QQKRKDTSPDLEKSC | 206 | Q86VG3 | |
| DERKQFRRKVKCPDS | 411 | Q8TE85 | |
| NTKSEALRTKPDVCK | 351 | Q9Y4C1 | |
| NTPKASEKEKACLVD | 1306 | Q9Y6J0 | |
| EKSSEKTDNCEKIPR | 1301 | Q96BY6 | |
| EVIKDSNPVDKCKLD | 1891 | Q96N67 | |
| IRPKQKVADSELACE | 821 | Q5THR3 | |
| KDIPKEDTNPDNCKV | 241 | Q5T6F0 | |
| SLNECFVKVPRDDKK | 131 | Q12948 | |
| DSCKAKLQEQLGPRK | 646 | Q5JV73 | |
| KCQERVQSKKAESPE | 496 | Q96PZ2 | |
| KLEPCDSNEEKRLKL | 126 | O15169 | |
| EKRCLNPESKAIKNL | 71 | P02778 | |
| LCADNPILKKDSKAR | 431 | Q9HC77 | |
| RKGKETKKVPCTDAN | 36 | A8MZ97 | |
| ERCFPEAEKLKQETK | 76 | Q6TDU7 | |
| CQKIKRPANSGELDK | 1196 | Q9BTC0 | |
| EPLKCGVSNKDIEKE | 171 | Q13443 | |
| KEKVTRKENSLCKLP | 111 | Q8IY85 | |
| ASLQCKLDEKDIPTR | 81 | Q96DS6 | |
| DEKGEKVRPSHKRCI | 186 | Q71RC2 | |
| KKNDPTFLEKKERCD | 516 | Q8N4S9 | |
| KCDSKLPAIDQTSVK | 91 | Q8NA82 | |
| DKCEPLEKQHEKERK | 181 | P02763 | |
| AKRTVKKCFPEDIAQ | 716 | Q08554 | |
| EAKVRGCPQEKEKSF | 426 | P05106 | |
| KAKRNLEQCTEELPK | 206 | Q8IYD9 | |
| CKICAENDKDVKIEP | 381 | P22681 | |
| KEDTASEKLSRCPVK | 271 | Q5T8I3 | |
| QKQKDCEEDLAKAEP | 3141 | Q9NYC9 | |
| KCFPQKKKEDRENIV | 3786 | Q8NDH2 | |
| KFCCRKLQEKIPAEA | 71 | Q8IX29 | |
| AENGVEEKKKACRSP | 31 | Q96HH9 | |
| STKRNHKCDPEKETV | 146 | Q9ULF5 | |
| DKSRKVLGCAKEQVD | 251 | Q68D06 | |
| KKQNKVDLEEKDEPC | 711 | P54277 | |
| PQCAEVRGFSDKDKK | 341 | P59044 | |
| VNSEETDLKNLCKPK | 1251 | Q5THK1 | |
| VEPKKCELSKNSDIE | 1581 | P0DJD0 | |
| DCEKKLERGQDIKVP | 396 | P17540 | |
| TNEKLDREKLCGPKE | 86 | Q9Y5E1 | |
| ARCTKIINADSEDPK | 96 | P35998 | |
| VACKQERFPKEEELK | 581 | Q4G112 | |
| KVEPKKCELSKNSDI | 1596 | Q7Z3J3 | |
| ILPKTEDRQCKALDS | 821 | O94972 | |
| QEITRCKSSEEKKPG | 166 | Q9HCM9 | |
| KQPEAKQRLLSEACK | 701 | Q8IYL2 | |
| DQTLKARIEIPSCKD | 1006 | A6NHR9 | |
| LSEQEELKKKPRRSC | 1696 | A6NHR9 | |
| SPKRLKAQKEDDVAC | 51 | Q93075 | |
| EAKKAAIKPLEQTEC | 2466 | Q8WXH0 | |
| PKELDEKNCQDKLET | 3146 | Q8WXH0 | |
| PGTEKLNEKEKELCQ | 371 | O75478 | |
| KAGLEDECKTLRQKV | 1506 | Q5JRA6 | |
| RKGSELTCPEDNKIK | 616 | Q7Z7B0 | |
| EEIPKRIKKADNSAC | 1621 | Q9P212 | |
| ESKVEPKKCELSKNS | 1586 | P0DJD1 | |
| KELEAAQKKKPSLCE | 326 | Q8IVM8 | |
| HKEEAKNTKLPRGCD | 531 | Q587J7 | |
| KKLREDAKIPACEES | 1086 | Q587J7 | |
| SPELEAALKKACTRD | 311 | Q7Z6Z6 | |
| EKKEPCLQGEAESKA | 41 | Q11206 | |
| IPEGQFIDSKKACEK | 731 | P11055 | |
| CDRAKKEKSASQDPL | 151 | O75192 | |
| SPEDRNDRCKKKAAA | 201 | Q5VTB9 | |
| AKNCALPVSKKDKER | 491 | Q8IX21 | |
| PCAQRKEKALEKSAS | 601 | Q6NSI8 | |
| LLVKKPEDRATAEEC | 301 | Q9UEE5 | |
| DKKEKDECTPTRKER | 911 | O15042 | |
| EVNRKLGKPDFDCSK | 176 | P55789 | |
| PEKEENEKSEPKICR | 311 | Q9UPV0 | |
| GHIAKDCKEPKRERE | 81 | P62633 | |
| NEPIKRDGKKECDIV | 1201 | Q7Z460 | |
| ALRDAVAKAVLECKP | 4336 | Q63HN8 | |
| EKKVQLACKERDAAK | 511 | P82094 | |
| KRKPKCPEDRTSEEN | 216 | Q9BU70 | |
| DKEAACLPLKKTNDQ | 506 | Q5W0Q7 | |
| LKDCSEKTALDDRPQ | 386 | Q9ULJ3 | |
| LNSPGSCLEKKEKEE | 446 | Q9H0M4 | |
| EDEVKCKSSKSNRPK | 36 | Q14CS0 | |
| LGVVPCVEKNRKKSE | 686 | Q8N2C7 | |
| EEAVKARKKEAANLC | 371 | Q14119 | |
| LSEACRTLAPEKDKA | 946 | O14924 | |
| DEQHLLERCKSPKSK | 56 | Q86YL5 | |
| PRSCNKLSREKADKE | 851 | Q96T58 | |
| PADNKCLLRATDGKK | 51 | P37108 | |
| LNPKAACLKRREEEK | 611 | P15923 | |
| KETSENALKKPVADC | 126 | O95757 | |
| DPISKDDVERCKQKD | 221 | Q9H4I3 | |
| VNKIAEKICGDLKDP | 26 | Q6UDR6 | |
| EKCIDDALRKNDFKP | 11 | Q9BX26 | |
| QKKNLEDEKEVCPKA | 101 | Q7Z6K1 | |
| DPPKSKCSRLQDDRK | 1966 | Q9HCK1 | |
| KPACEDVKAKPVSDN | 1246 | P53804 | |
| EPAGKKLSDRKECEV | 486 | Q14151 | |
| PCAENRLDTKEEKSV | 796 | Q12888 | |
| SRLVVVKKAKADPDC | 261 | Q9BW85 | |
| EAVKDPCFSAKRRKV | 396 | Q8IYW5 | |
| NSCKSEKLPEDLTVK | 501 | P37275 | |
| ETEEPAAKKRKCPES | 481 | Q9UJA5 | |
| QCECRPKKKDSAVKP | 121 | P49765 | |
| EVKIAKNSDGRECIK | 91 | Q8WV37 | |
| CERKEKASKQERENP | 31 | Q3LFD5 | |
| NELVDKKCKSDIEKP | 126 | Q8N3Z6 | |
| SQVRTEPPKEKNCKE | 111 | O75362 | |
| ENCEALAAKPKTCRK | 251 | Q8NAP3 | |
| RAKTIDLCNNPKTKE | 1461 | Q9NYU1 | |
| RRNTDKKGKPEIACE | 501 | Q9HBM0 | |
| QQRFAKEKTPSKCEI | 176 | Q96LW1 | |
| KLDKKQDDLAPSETC | 811 | Q5TAX3 | |
| KVADEEKPKKSSLCR | 1776 | Q5T4S7 | |
| NRDQGVKCDPESEKK | 61 | P48595 | |
| KETCQRLLEKPKDAD | 1546 | Q5T200 | |
| EALDTTKDPCQKVKC | 81 | Q92563 | |
| CIKPNEDKVAGKLDE | 601 | B0I1T2 | |
| ECVVKDNDFEPRALK | 466 | P29120 | |
| FSRECEDQKQIKKPE | 21 | Q96NK8 |